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ABSTRACT OF THE DISSERTATION
TUNING THE COORDINATION PROPERTIES OF PYRAZOLES TOWARDS SPECIFIC
APPLICATIONS VIA JUDICIAL CHOICE OF PERIPHERAL SUBSTITUTION
by
Shambhu Kandel
Florida International University, 2019
Miami, Florida
Professor Raphael G. Raptis, Major Professor

The tunability of pyrazoles make them probably the most versatile ligands, and this is one of the
right reasons for its use. Pyrazolyl ligands have intrinsic antibacterial property. Synthesis of
pyrazolyl complexes with silver can be of great interest in biological applications. The urgent
need to find an alternative of currently used antibiotics has been recognized as a big challenge of
the 21st century. Many ideas have been proposed, but the re-emergence of silver medicine could
be the most promising alternative to overcome the limitations of these antibiotics. In spite of the
popularity of Sonogashira coupling reactions, there is still a room to improve the catalytic
system to overcome the existing limitations. N-N donor ligands with palladium metal have
shown better catalysis over the conventional ones. This work presents the synthesis of pyrazolyl
ligands and their complexes with silver, palladium and mercury and exploring their applications
accordingly. The work has been divided into four distinct regions of applications as follows.
Eight

new

silver

pyrazolyl

complexes

with

triphenylphosphine

or

1,3,5-triaza-7-

phosphaadamantane as a co-ligand have been synthesized, characterized with single crystal Xray, spectroscopic techniques and elemental analyses and their antibacterial property against
Pseudomonas aeruginosa was investigated with a soft tissue and skin infection model. Water
soluble complex was found to be more efficient than silver nitrate. This compound releases Ag+

vii

slower than AgNO3 and inhibits the physiological problems associated with the rapid release of
Ag+. Five new tripodal (1R) pyrazolyl ligands were synthesized and their application in selective
sensing of picric acid (PA) were successfully investigated. They are promising in sensing the
picric acid in all physical states. Seven new mercury pyrazolyl complexes with broad versatility
in geometry and nuclearity were synthesized. Two of them were used to extract mercury (Hg 2+)
from the mixture of Ln3+ in aqueous solution using chloroform as extractant and found
promising. Nine palladium pyrazolyl complexes including three water soluble ones were
synthesized. Two of them were used to catalyze the Sonogashira cross coupling reactions. The
catalysts worked well in copper free, open air and mild reaction conditions. Reactivity of Pdhexamer was also studied.
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CHAPTER 1
1.1. Introduction
1.1.1. Pyrazoles: The ligand of choice
Ludwig Knorr synthesized phenazone; the first reported pyrazole compound in 1883.1 2 Pyrazoles
given in Scheme 1 are quite versatile ligands and have been studied intensely over the past 40
years as an important family of ligands in coordination chemistry.3 Physical and chemical
properties, such as acidity/basicity, steric and electronic environment, and solubility, can be tuned
easily by varying the substituents on the 3-, 4- and 5-positions of the ring.3-5 Pyrazoles can also be
utilized to build monopodal to polypodal molecular platforms.6 In 2009, Halcrow et al. reported
22 coordination modes (Scheme 1.2) of the pyrazoles and pyrazolide ions. The most common
coordination mode for pyrazoles is binding to a metal in the monodentate, 1-fashion, through the
N2 atom. Deprotonated pyrazolate anions, however, bind the metals as 2-N, N’ bridges and most
the common coordination modes are the chelating and bridging exo-bidentate (-pz) ones. They
are known to be ideal for binding the metals in exo-bidentate fashion maintaining the metal
centers in close proximity, i.e., approximately 3 Å.7 Pyrazoles are -excessive five membered
heterocycles, i.e. a poorer -acceptor, hence good -donor for hard metals, unlike six membered
N-donor heterocycles, such as bipyridine or terpyridine. However, hardness can be tuned to a
desirable extent by substituting various pendant peripheral groups on the ring, making these
ligands compatible with very hard to very soft metal acceptors.8
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Scheme 1. 1. Pyrazole and its substituted derivatives. Modified and redrawn from Halcrow et al.3

Scheme 1.2. The twenty two known coordination modes of pzH and pz-. Redrawn from Halcrow
et al.3

2

Some pyrazoles have proven to be biocompatible, which prompted the study of their medicinal
(biological) properties.9 Pyrazoles have active pharmacophores which make them compounds of
medicinal value. They are found to be effective for many health problems, such as
inflammation,10 cancer,11 pain,2 microbial12 and viral infections.13 Pyrazole derivatives are widely
used in sensing applications. Recognition of cations such as Cd(II), Zn(II), Hg(II)14 and
nitroaromatics (e.g., picric acid) are some of the most commonly studied areas. Some pyrazoles
have AIEE properties, making them good candidates for chemical sensors, biological probes and
components for the fabrication of organic LEDs.15 Tripodal tris(pyrazolyl) receptors have been
used for the selective binding of NH4+ and found promising.16-18 Tetraaryl pyrazole
derivativatives have been successfully used for the sensing of nitroaromatics, because of their
AIEE phenomenon.19

18

The tunability of the ligands using various pendant substituents make

them great extractants for very hard to very soft metal cations.20-22 Pyrazole ligands are also
proven as useful ligands in catalysis.23
1.1.2. A brief review of silver pyrazolate complexes
Monomeric, dimeric, trimeric, tetrameric and polymeric silver pyrazolate complexes have been
reported in the literature. Polymers are the most common silver pyrazolates, followed by trimers
and dimers. Buchner in 1889 synthesized a insoluble silver salt [Ag(pz)]n, and after that all the
derivatives were claimed to be a polymeric. Polymeric silver pyrazolate; Ag(pz)n structure was
first determined by powder X-ray diffraction in 1994.7

24

Compounds Ag2(pz)2(pph3)2 and

Ag2(pz)2(pph3)3 are the first two silver pyrazolates dimers with PPh3 as a coligand revealed by
Cambridge structural database.24a Omary et al. in 2003 published a paper reporting a silver
pyrazolate dimer, [(3,5-(CF3)2-pz)Ag(2,4,6-collidine)]2, the first ever study of the luminescence
properties for silver pyrazolates.25 Several binary silver pyrazolate complexes with interesting
structural features have been reported in the literature in the last two decades, but research on
their applications is lacking.26
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The silver pyrazolate trimer, [(Ag(-3,5-Ph2-pz)]3.2THF was the first reported silver trimer and
structurally characterized by single crystal X-ray diffraction.27 Other groups have reported similar
trimeric silver pyrazolate complexes since then.28 A trimer [Ag(pz)]3 was though synthesized and
characterized by X-ray powder diffraction in 1994.7 Rasika Dias in 2000 published a paper
reporting silver pyrazolate trimer with 3,5-(CF3)2-pz: [{3,5-(CF3)2-pz}xAg]3.29 All the silver
pyrazolates published earlier were limited on pz and 3,5-diaryl substituted pyrazolates.
Compounds [Ag(pzIN)]6 and [Ag(pzbisIN)]n were reported in 2004 along with their magnetic
measurements;30 As Ag(I) is diamagnetic, the magnetism of these compounds was attributed to
the organic radical moieties. A new crystalline form of [Ag3(-3,5-Ph2pz)3]2 was reported in 2005
showing significant intermolecular argentophilic interaction [Ag…Ag = 2.971(1) Å] between two
independent trimer units.31 Several groups reported their work on the silver pyrazolate trimers
(most of them are dimers of trimers with independent trimer units).32-51
Group 11 metals exhibit metallophilic interaction; the aurophilic is stronger than the argentophilic
interaction, which is easily overcome by the sum of weak dipolar interactions.52 Five new silver
pyrazolate trimers [Ag(μ-pz*)]3 (Pz* = 3,5-Ph2-pz, 3-Me-5-Ph-pz, 4-Br-3,5-Ph2-pz, 4-Br-3-tBu-pz
and 3-(o-Cl-C6H4)-pz were reported in 2012 and the effect of substituents on the supramolecular
aggregation were studied.53 Among the metals of group 11, silver is most acidic in nature.
Addition of electron withdrawing substituents on the pyrazole increases the acidity whereas,
electron donating substituents decrease the acidity.54 Unlike the compound reported previously,
where intermolecular interaction [(Ag…Ag = 2.971(1) Å] was observed with the 3,5
diphenylpyrazolato silver trimer, {[Ag(3,5-Ph2-pz)]3}2,32b they did not observe any intermolecular
argentophilic interaction in [Ag(3,5-Ph2-pz)]3·2THF. Absence of argentophilic interaction might
be either because of weakly coordinating solvents, or the solvent enabling - or C-H…
interactions.53 A trigonal prismatic Ag3pz3 (pz= C18H12N4Ph4; a bipyrazole ligand) for the first
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time with bipyrazole was synthesized by Duan et al.55 In 2014, Chen et al. reported three new
silver pyrazolate trimers with Cl, I or Me in C4 position and Ph in C3 and C5 position. He depicted
the weak Ag3…X (Cl, Br53, I) interactions.56
Although polymeric Agpz are the most common in literature followed by trimers, crystal
structure of a few tetranuclear silver pyrazolates have been reported. A neutral Ag4N12; [{3,5(CF3)2-pz}4Ag4(C4H4N2)2] was reported in 2005.57 However, a silver tetramer [{Ag(-3,5-tBu2pz)}4. CH2Cl2] with only pyrazole ligands was first synthesized by G. Yang and R. G. Raptis.58
Scheele et al. in 2008 synthesized two complexes including a double crowned complex.59 Kiyoshi
Fujisawa et al. in 2010 reported the same compound as (Yang and Raptis, 2007).32a
Most of the hexamers reported are dimers of trimers as a result of several weak interactions
including argentophilic interaction.30

31

Because of the poor solubility, the X-ray powder

diffraction technique was used for the structural elucidation of polymeric silver pyrazolates.47
1.1.3. Sensing of nitro-aromatics using AIEE property
Most of the chromophoric organics and polymers have strong emission in dilute solution but
weak in thin film form, e.g., formation of aggregation quenches the emission behavior of the
chromophore.60 Although light emission induced by aggregation is an exceptionally rare
phenomenon, existence of light emission was already reported for small organic molecules,61
discovery of aggregation induced emission (AIE) and aggregation induced emission enhancement
(AIEE) phenomena, however, Tang et al.62 and Park et al.63 took the sensing of chemicals using a
ligand containing AIEE luminogens into a new horizon: Under the UV light, 1-methyl-1,2,3,4,5pentaphenylsilole in a TLC plate with a solvent was faint but, after the solvent evaporated the
spot became clearly visible.62 The property was different than the property exhibited by many
luminophores. The unique and rare phenomena observed were because of co-planarization of the
phenyl rings, which in the solution state are twisted. The restricted rotation of the phenyl ring
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favors the enhancement of the photoluminescence property. 62 The phenomenon was just opposite
of “aggregation quenches light emission.” A representative image of conformational rotamers in
solution and in aggregation is shown in Scheme 1.3.

Scheme 1.3. Conformational rotamers. Modified and redrawn from Luo et al.62
After the unusual finding by Tang et al.62 several studies have been carried out on sensing using
organic molecules containing luminophores having the AIEE property.64 Upon aggregation,
tetraaryl and triaryl pyrazoles show significant enhancement in their photo emission.64
Mukundam et al. in 2013 synthesized the tetraaryl pyrazole polymers for the sensing of picric
acid.65 Aggregation induces the enhancement on emission spectra as a result of restriction on
intramolecular rotation. They also studied the intermolecular rotation restriction phenomenon at
various temperatures, and found that AIEE is enhanced when the temperature is lowered.
Pyrazole-porphyrin conjugates were studied for sensing of several cations, such as Ag(I), Zn(II),
Hg(II) and Cd(II) by spectrophotometric and spectrofluorometric titrations in solution and also in
gas phase with promising results.18 Tripyrazolyl ligands were also found to be effective for
selective sensing of NH4+ by NMR titration, florescence and X-ray crystallography studies.66
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1.1.4. Mercury pyrazolates in literature
The Cambridge Crystallographic Data Center contains the crystal structures of mercury
pyrazolates in ten different publications to date.67-76 Although a few reports on the synthesis of
mercury

pyrazolates

had

been

reported

earlier,

methyl[tetrakis-(pyrazol-1-y1)borato-

N,N']mercury(II); [MeH g(B(pz)4] was the first reported crystal structure of mercury pyrazolate
in 1987.67 The mercury atom is coordinated with the two pyrazolates in the complex in T-shaped
coordination geometry with a stronger Hg-N bond [2.07(4) Å] from one pyrazolate and a weaker
Hg-N bond [2.65(4) Å] from second pyrazolate. Exploring compounds of Hg(II) and MeHg(I)
with coordination number higher than two has been of great biological importance.68 Solution
studies, however, are complicated by the lability of mercury compounds.68 Aime et al. in 1994
synthesized and crystallized the linear,, 2-coordinate MeHg(pz)4B and the
coordinate MeSHg(3,5-Me2-pz)3BH and

T-shaped

3-

EtSHg(3,5-Me2-pz)3BH. Solid state NMR was

consistent with the crystal structure, proving that lability is not an issue in the solid state.68 Two
compounds [(5-Me)thien-2-yl]Hg-(-Pz)2B(Pz)2 and HB [(3,5-Me2-pz)3]HgCN were synthesized
and X-ray data were reported by Lobbia et al. in 1996 and 1997.3 70 Unlike previously reported
mercury pyrazolates (which were either T-shaped or linear), HB [(3,5-Me2-pz)3]HgCN has
distorted tetrahedral geometry, but with one of the bonds significantly weaker than the rest.
Lobbia et al. in 1998 synthesized and crystallized [HB(3,5-ph2-pz)3HgC2H5, the first reported
complex with true and rigid tetrahedral geometry.71 Mercury complexes with high coordination
numbers are always desired for the activation and cleavage of Hg-C bonds in both bacterial
degradation77 and other reactions, such as symmetrization of the aryl mercury salts.78 Masciocchi
et al. in 1999 synthesized two mercury pyrazolate polymers, [Hg(pz)(NO3)]n and [Hg(pz)2]n, and
elucidated the structure with powder X-ray diffraction; their poor solubility in various solvents
did not allow the growth of single crystal for the single crystals. Unsubstituted pyrazole with
Hg(NO3)2 gave the deprotonated polymer without any deprotonating agents. However, addition of
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Et3N on the reaction medium yielded a Hg(pz)2 monomer.72 Masciocchi in 2006 synthesized the
first C-mercuriated pyrazole:73 [{Hg(ac)(µ-κC:κN-Hdmpz)}n] along with the two conventional
coordination compounds [{Hg3(-ac)3(-pz)3}n] and [{Hg3(-ac)3(-dmpz)3}n]. Kiyoshi Fujisawa
in 2006 reported the crystal structure of [Hg(Cl){HB(3,5-iPr2-pz)3}] with tetrahedral geometry.74
Hitzbleck et al. in 2007 reported a trinuclear Hg complex; [Hg3(iPr2-pz)4(C6F5)2] with two Hg in a
trigonal planar and one mercury in tetrahedral coordination mode.75 In 2018 N. Mosca et al.
synthesized Hg(Me2BPZ) and characterized it by powder diffraction.76 The metal center in the
compound Hg(Me2BPZ) has a see-saw (4 coordinate) coordination geometry. The majority of
mercury pyrazolylborates are represented by Scheme 1.4.

Scheme 1.4. R=CH3, X= SR, Y=H68, R=H, X=CN, Y=pz-70, R=Ph, X=Et, Y=H.71
1.1.5. Liquid-liquid extraction of mercury
Liquid-liquid extraction, it is one of the most convenient techniques in separation chemistry.
Mercury salts along with the interfering metals ions have high preference in aqueous phase and
the highly lipophilic, soft organic ligands extract mercury out of aqueous solution. Garcia et al.
designed a series of dithiophosphate compounds (CH3)(CH2)nS2P(OC6H4)2 (n=0 to 4) and
extracted Hg(II) selectively in toluene from an aqueous mixture of Ag(I), Cd(II), Pb(II) and
Bi(III) nitrates.79 A dithiophosphate with a long alkyl chain had better extracting ability than
dithiophosphates with shorter chains. Mane et al. used 2-octylaminopyridine to extract Hg(II) in
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chloroform from a mixture of Cd(II), Pb(II), Zn(II), Sb(III), Sn(IV), Tl(I), and Cr(VI).80 They
studied the extraction in various conditions, such as pH, concentration, etc., and proved that
extraction was more eficient in alkaline conditions (pH range 8.3 to 10). Cyanex 302 was used for
the extraction of mercury in highly acidic medium.81 Several other works in the literature have
been reported for the extraction of mercury.
1.1.6. Palladium pyrazolate complexes
Mononuclear and polynuclear palladium pyrazolyl complexes have been reported with the
majority being binuclear ones.82-84 Monomers usually are obtained with the protonated
pyrazoles.85 However, addition base deprotonates the 1H of pyrazoles resulting in higher
nuclearity pyrazolyl complexes. The design of binuclear metal complexes is of research interest
from the standpoint of catalysis,86 multi electron transfer reactions,87,

88

and metal-metal

interactions.89 Pons et. al. synthesized first binuclear palladium pyrazolate with a Pd2(pz)4
environment.90 Baran et al. reported a trinuclear palladium pyrazolate; [Pd(-3-Ph-pz)2]3.84 They
synthesized the compound; [Pd(-3-Ph-pz)2]3 using two different methods and it was the first Pd
trimer reported in the literature.

Umakoshi et. al. synthesized two trinuclear palladium

pyrazolates; [Pd3(-pz)6] and Pd3(-4-Me-pz)6, a dinuclear complex; [Pd2(-3-tBu-pz)2(3-tBupz)2(3-tBu-pzH)2], a mononuclear complex [Pd(pzH)4Cl2] and a heteronuclear complex;
[Pd2Ag2(-3-tBu-pz)6].82 A set of polynuclear complexes, i.e., [Pd(-pz)]n, [Pd(-Me-pz)2]n,
[Pd(-Me2-pz)2]n and [Pd(-I-pz)2]n were characterized by infrared spectroscopy.83 Their thermal
behaviors were studied by TG and DTA and demonstrated that substitution in 4-position does not
affect the stability but, substitutions in the 3- and 5-positions reduce the stability of polymeric
chain. Decomposition ultimately leads to metallic palladium, identified by X-ray powder
diffraction.

9

1.1.7. Palladium in Catalysis
Catalysis is one of the most important applications of metal complexes. The organic ligands of
poly-nuclear complexes give a variety of chemistry and they are essential for the reactions that
require milder conditions.91 Sonogashira and Mizoroki-Heck couplings92

93

are widely studied

palladium-catalyzed reactions. Investigations have shown that catalytic activity of water soluble
palladium compounds is superior or comparable to that of water insoluble ones.94
Palladium carboxylate, [Pd(µ-OAc)2]3, is one of the earliest examples of a catalyst used in C-H
activation of benzene.95 Palladium catalysts cleave terminal and internal amide bonds near
histidine and methionine residues in peptides and proteins, unlike that of Co(III) complexes that
cleave only the N-terminal amino acids.96 Binuclear complexes with stable bridging and relatively
labile terminal ligands are expected to have better catalytic applications than mononuclear ones.97
In spite of substantial work already accomplished in cross coupling reactions, there is still room
for improvement.98 The crystallographic details of palladium acetate trimer, [Pd(µ-OAc)2]3, were
first investigated by Skapski et al.99 and comparative studies of [Pd (µ-OAc)2]3 with [Pd3(µ-pz)6],
[Pd3(µ-4-Me-pz)6]82 and [Pd3(µ-3-Ph-pz)6]84 have shown that they are structurally parallel. Table
1.1 gives summarizes a structural comparisons among palladium acetate and three palladium
pyrazolate trimers. Palladium pyrazolates are expected to be less labile in the solution than the
corresponding carboxylates.
Table 1.1. Structural comparison between Pd-acetate and Pd-pyrazolate trimers. Interatomic
distances and angles are averages.

Compounds
Pd-Pd (Å)
Pd-O/N (Å)
M-M-O/N (°)
M-N-N(°)

[Pd3(µ-OAc)6] 99
3.140
1.99
76.3
129.6 (M-O-C)

[Pd3(µpz)6]82
3.047
2.017
65.18
114.8

[Pd3(µ-4-Mepz)6]82
3.054
2.018
65.19
114.8
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[Pd3(µ-3-Phpz)6]84
3.010
2.002
65.01
114.9

Although palladium acetate is a widely used homogenous catalyst, it is insoluble in water, which
limits its application in green chemistry.100 The structural similariry of Pd-pyrazolyl complexes
with well estabilished Pd-acetate catalysts makes persuing the former system in catalytic studies a
worthwhile endeavor.

1.2. Objectives
Considering the fascinating amenability through suitable functionalization of 3-, 4- and 5positions of the pyrazolyl ligand, we have undertaken the synthesis of their silver(I),
palladium(II) and mercury(II) complexes aiming towards diverse applications.101 Pyrazole and its
derivatives have been employed to synthesize a wide range of transition metal complexes that can
be “fine tuned” with regard to their steric and electronic properties through suitable derivatization
of the ligand. Silver, palladium and mercury are relatively week to moderate Lewis acids.
Pyrazole(s) can bind these metal centers either in a monodentate or in bridging bidentate fashion.
In case of mercury(II), the pyrazole derivatives are employed with an objective to serve as
extractants of Hg(II) embedded within mixed alkaline nuclear wastes. The idea was to extract the
Hg(II) from aqueous to the organic phase through complexation. Along this line, indeed various
mercury(II) pyrazole/pyrazolato complexes of varied nuclearity have been isolated and
characterized (including X-ray structural studies). The steric and electronic nature of the
substituents of these pyrazole derivatives significantly influenced the nature of the complexes
isolated. In addition, initial assessment shows selective extraction of mercury(II) from the mixture
of lanthanides;. In a step further, design and synthesis of a fluorescent tripodal pyrazole derivative
presents the opportunity of its utilization in sensing applications.
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Manipulation of solubility was another reason for the choice of pyrazole.102 Our initial objective
was to synthesize water-soluble pyrazolate complexes for biological applications. We have
carried out the project aiming to accentuate the therapeutic application of silver pyrazolates and
demonstrate that silver(I)-based therapeutic agent might prove to be a viable alternative to
currently used antibiotics, many of which have become ineffective because of the emergence of
severe multidrug resistant (MDR) pathogens. The well-known pharmacokinetic profile and
biocompatibility of pyrazoles make them excellent candidates to achieve the goal.103 In this
endeavor we have synthesized a new family of Ag(I) pyrazolate dimers (both hydrophilic and
lipophilic ones) that exhibit significant growth inhibition towards colonies of a notorious
nosocomial pathogen, P. aeruginosa (prevalent with burn wound infections), with the aid of a
soft tissue and skin infection (SSTI) model.
On another front, we attempted to synthesize water-soluble palladium pyrazolato complexes for
green catalysis. New water-soluble palladium(II) complexes have been synthesized and
structurally characterized. These Pd-pyrazolate systems are expected to be potent for catalytic
applications. For example, two of these Pd(II) complexes demonstrated excellent catalytic
efficiency for Sonogashira cross-coupling reactions, circumventing the limitation of
commercially used Sonogashira catalysts.104 Although beyond the scope of the current research, it
is anticipated that pyrazolyl ligands might be used in the future for chelation therapy, replacing
the currently used sulfur-containing ligands,105 which cause adverse biological reactions.
Finally, considering the efficient sensing characteristics, new tripodal pyrazole-based platforms
were designed, and their aggregation induced emission enhancement (AIEE) property was
exploited with regard to their use as sensors for explosives (picric acid) in both solution and solid
states.
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In summary, new Hg(II), Ag(I) and Pd(II) complexes incorporating pyrazoles have been
synthesized and characterized. Apart from basic research interests, the chemistry extends to
broader areas of applications of interest.
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2.1. Abstract
Eight new dinuclear silver(I) complexes, namely [Ag2(-4-Cl-pz)2(PPh3)4] [2.1], [Ag2(-4-Cl
pz)2(PPh3)3] [2.2], [Ag2(-4-NO2-pz)2(PPh3)4] [2.3], [Ag2(-4-NO2-pz)2(PPh3)3] [2.4], [Ag2(-4Cl-pz)2(PTA)4] [2.5], [Ag2(- 4-Cl-pz)2(PTA)2] [2.6], [Ag2(-4-CH3-pz)2(PTA)2] [2.7] and
[Ag2(-3-CH3-pz)2(PTA)2]

[2.8]

triazaphosphaadamantane) have

(where

pz

=

been synthesized

pyrazolate
and

and

PTA

=

1,

3,

5-

structurally characterized. The

coordination geometry of both silver centers in complexes 2.1, 2.3 and 2.5 is distorted tetrahedral,
while in case of complexes 2.2 and 2.4, one of the Ag centers resides in a trigonal planar
environment. The coordination geometry on both silver centers in complexes 2.6, 2.7 and 2.8 is
trigonal planar. The two -pyrazolates act as bridges between two Ag atoms. Complexes 2.5-2.8
are water soluble. Complex 2.5 exhibits strong antimicrobial actions against a Gram-negative
nosocomial pathogen Pseudomonas aeruginosa. The zone of bacterial clearance by complex 2.5
in soft tissue and skin infection (SSTI) model is found to be superior to that by silver nitrate. The
biological activities of other water-soluble complexes (2.6-2.8) are under study.

2.2. Introduction
Antibiotic resistance is currently an alarming issue1 and several health organizations throughout
the World have already declared bacterial resistance towards antibiotics as “catastrophic”.2 The
Infectious Disease Society of America (IDSA) has expressed significant concern on antibacterial
resistance, in particular regarding the multi-drug resistant bacteria (MDR), which have been
singled out as an imminent threat to US public health.1 Among the Gram-positive variety,
methicillin-resistant Staphylococcus aureus (MRSA) is annually responsible for more loss of life
in US than the infectious HIV/AIDS disease.1, 3 Gram-negative strains have also started showing
resistance towards a range of antimicrobials. The notorious Gram-negative hospital infections are
mostly caused by Klebsiella pneumonia, Pseudomonas aeruginosa, and Acinetobacter
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baumannii.4 These circumstances have prompted the research community in recent years to focus
on developing alternative chemotherapeutics to combat antibacterial resistance.
Ionic or bioactive silver (Ag+) has been historically found to be a quite effective antimicrobial
against a broad range of microorganisms.5 At controlled concentrations, ionic Ag has been widely
used in various commercially available healthcare products and also as antibacterial agent. 5c
Silver is also known as “oligodynamic” because of its ability to exert its antimicrobial actions
even at very low concentrations.6 In addition, Ag+ ions interact with bacteria by several different
mechanisms, making difficult for the pathogens to develop resistance.7 In bacteria, Ag+ interacts
with the nucleophilic amino acid residues,8 inhibits the function of oxidative enzymes,8 promotes
generation of reactive oxygen species (ROS)8 and interferes with DNA replication.9 These
observations have led to silver-based antimicrobials, particularly effective against burn wound
infections.10 Silver nitrate and silver sulfadiazine (SSD) are used extensively as topical
antimicrobials for severe burn wounds.11 Slow and sustainable delivery of Ag+ ions under a
physiological milieu by dissociation of the topically applied compound is crucial to its exerting
effective antibacterial action, ensuring also that the Ag-based antimicrobial is not being over
used, which might cause other undesirable side effects. Appropriately designed Ag(I)
coordination complexes can meet these requirements.12
Our group has previously studied some silver pyrazolate and triazolate materials with regard to
their porosity, structural and supramolecular chemistry.13 This has prompted us to extend our
work to new Ag(I) pyrazolates and assess their antibacterial efficacy (if any), towards a Gramnegative strain, abundant in the sites of burn wound infections. Pyrazoles themselves have been
reported to exhibit a wide range of biological activities, including antimicrobial, anti-fungal, antiinflammatory, anti-convulsant, anticancer, and neuroprotective.14 Several pyrazole derivatives
have already found their place in some clinically approved non-steroidal anti-inflammatory drugs
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(NSAIDs).14 The pyrazole 3, 4, 5-positions are amenable to functionalization, offering the
opportunity to “fine tune” the chemical properties of their metal complexes. Herein, we report the
synthesis and structural characterization of eight pyrazolate-bridged dimeric Ag(I) complexes,
namely,

[Ag2(-4-Cl-pz)2(PPh3)4]

(2.1),

[Ag2(-4-Cl

pz)2(PPh3)3]

(2.2)

[Ag2(-4-NO2-

pz)2(PPh3)4] (2.3), [Ag2(-4-NO2-pz)2(PPh3)3] (2.4), [Ag2(-4-Cl-pz)2(PTA)4] (2.5), [Ag2(- 4-Cl
pz)2(PTA)2] (2.6), [Ag2(-4-CH3-pz)2(PTA)2] (2.7) and [Ag2(-3-CH3-pz)2(PTA)2] (2.8) (where
pz = pyrazolate and PTA = 1, 3, 5-triazaphosphaadamantane) (Scheme 2.1), along with a
preliminary report of antibacterial properties of 2.1, 2.2 and 2.5 against the Gram-negative
bacterial strain P. aeuroginosa. Complexes 2.1-2.4 are soluble in organic solvents but barely
soluble in aqueous media. To circumvent this limitation, 1, 3, 5-triazaphosphaadamantane (PTA)
has been employed as a co-ligand to synthesize the highly water-soluble complexes 2.5-2.8. By
virtue of its ability to H-bond strongly with water molecules through the bridgehead N atoms,
PTA has gained considerable attention as an auxiliary ligand for various catalytic reactions. 15 Due
to its biocompatibility and minimal intrinsic toxicity,16 PTA has also been utilized in the
development of transition metal-based anticancer agents with excellent antiangiogenic and
antimetastatic properties.17

Scheme 2.1. Eight complexes synthesized for this work.
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2.3. Experimental
2.3.1. Materials and method
Reagent grade chemicals were purchased from Aldrich Chemical Co, Alfa Aesar, Fisher scientific
and Acros Organics. THF was distilled over Na/benzophenone and CH2Cl2 was distilled over
CaCl2/CaH2 prior to use. NMR spectra were recorded on 400 MHz or 500 MHz Bruker Avance
spectrometers. FT-IR spectra were recorded with a Perkin Elmer Spectrum 100 FT-IR
Spectrometer. Elemental analyses (CHN) were performed by Galbraith Laboratories, Inc. at
Knoxville, TN.
2.3.1.1. Synthesis of [Ag2(-4-Cl-pz)2(PPh3)4] [2.1]
10.3 mg (0.101 mmol) 4-Cl-pzH and 22.9 mg (0.10 mmol) Ag(PhCOO) were added to 5 mL THF
and the reaction mixture was stirred at room temperature for 12 h. After this time, the mixture
was filtered and the insoluble polymeric [Ag(4-Cl-pz)]n was collected by filtration and was
thoroughly washed with CH2Cl2 to remove any unreacted starting materials. The solid was then
dried under vacuum (Yield, 19.5 mg (93 %), based on Ag(PhCOO) as a limiting reagent).
Subsequently, 19.5 mg (0.093 mmol) of the dry solid was suspended in 5 mL CH2Cl2, 131 mg
PPh3 (0.50 mmol) was added and the reaction mixture was stirred at room temperature for 20 min
resulting in a clear colorless solution. The solvent was removed under reduced pressure and the
resulting solid was thoroughly washed with hexanes to eliminate any excess PPh 3. Finally the
solid material was dissolved in CH2Cl2 and carefully layered with hexanes. X-ray quality blockshaped colorless crystals of 2.1. Yield: 60 mg (88%). Anal. Calcd for C78H64N4Cl2P4Ag2 (1467.93
g mol-1): C, 62.82; H, 4.39; N, 3.82. Found: C, 62.73; H, 4.60; N, 3.51. IR (ʋmax, cm-1): 3046(w),
1477(m), 1432(s), 1268(w), 1174(w), 1093(m), 1024(m), 952(m), 815(w), 742(s), 692(s), 615(w).
H NMR (400 MHz, CDCl3) (ppm): 7.55 (s, 4H, -CH/pz), 7.69-7.32 (m, 60H, -CH/PPh3). 31P

1

NMR (12.35 MHz, CDCl3, ppm): -30.03 (PPh3 at -5.89 ppm as reference).
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2.3.1.2. Synthesis of [Ag2(-4-Cl-pz)2(PPh3)3] [2.2]
This complex was synthesized in the same way as complex 2.1, except 1.5 equivalents of PPh3
was used in this reaction. The solid obtained from the colorless reaction solution was washed
thoroughly with hexanes and dried under vacuum. Next, this solid was dissolved in CH2Cl2 and
layered with hexanes. Single crystals (as colorless blocks) of complex 2.2 were obtained after one
week. Yield: 52 mg (92%). Anal. Calcd for C60H49N4Cl2P3Ag2 (1205.64 g mol-1): C, 59.77; H,
4.10; N, 4.65. Found: C, 59.29; H, 3.99; N, 4.56. IR (ʋmax, cm-1) 3048(w), 1477(m), 1432(s),
1268(w), 1174(w), 1093(m), 1024(m), 952(m), 817(w), 744(s), 692(s), 615(w). 1H NMR (400
MHz, CDCl3)  (ppm): 7.41 (s, 4H, -CH/pz),7.39-7.27 (m, 45H, -CH/PPh3). 31P NMR (CDCl3,
ppm): -27.82 (PPh3 as reference).
2.3.1.3. Synthesis of [Ag2(-4-NO2-pz)2(PPh3)4] [2.3]
This complex was prepared by the same procedure as 2.1, using [Ag(4-NO2-pz)]n polymeric
precursor (this polymer was obtained from the reaction of Ag(PhCOO) and 4-NO2-pzH following
the same reaction conditions employed to isolate [Ag(4-Cl-pz)]n polymer) and excess PPh3.
Yield: 58 mg (88%). Anal. Calcd for C78H64N6O4P4Ag2 (1489.04 g mol-1): C, 62.92; H, 4.33; N,
5.64. Found: C, 61.90; H, 4.28; N, 5.66. IR (ʋmax, cm-1): 3050(w), 1496(m), 1475(s), 1430(m),
1392(s), 1259(s), 1147(m), 1089(m), 1002(m), 852(w), 811(w), 742(s), 690(s), 601(s); ). 1H
NMR (400 MHz, CDCl3)  (ppm): 7.91 (s, 4H, -CH/pz),7.70-7.24 (m, 60H, -CH/PPh3). 31P NMR
(CDCl3, ppm): -29.40 (PPh3 as reference).
2.3.1.4. Synthesis of [Ag2(-4-NO2-pz)2(PPh3)3].4H2O [2.4]
This complex was prepared by the same procedure as 2.2, using [Ag(4-NO2-pz)]n polymeric
precursor and 1.5 equivalent of PPh3. Yield: 52 mg (94%). Anal. Calcd for C60H49N6O4P3Ag2
(1298.70 g mol-1): C, 55.44; H, 4.39; N, 6.46. Found: C, 56.22; H, 4.29; N, 6.28. IR (ʋmax, cm-1):
3050(w), 1479(s), 1432(m), 1396(s), 1263(s), 1151(m), 1093(m), 1002(m), 854(w), 811(m),

28

742(s), 692(s), 603(s). 1H NMR (400 MHz, CDCl3)  (ppm): 7.81 (s, 4H, -CH/pz),7.38-7.22 (m,
45H, -CH/PPh3). 31P NMR (CDCl3, ppm): -27.31 (PPh3 as reference).
2.3.1.5. Synthesis of [Ag2(-4-Cl-pz)2(PTA)4]. PTA [2.5]
This complex was prepared by the same procedure as 2.1, using [Ag(4-Cl-pz)]n polymeric
precursor and 4 equivalents of PTA. Yield: 25 mg (51%). Anal. Calcd. for C36H64N19Cl2P5Ag2
(1787.17 g mol-1): C, 35.90; H, 5.36; N, 22.09. Found: C, 36.51; H, 6.04; N, 21.10. IR (ʋmax, cm1

): 3197(s), 2944(w), 2906(w), 2275(w), 1637(w), 1448(m), 1411(s), 1295(s), 1241(s), 1105(m),

1037(s), 1012(s), 970(s), 948(m), 900(s), 794(m). 1H NMR (400 MHz, D2O)  (ppm): 7.67 (s,
4H, -CH/pz),7.32 – 7.23 (m, 48H, -CH/PPh3). 31P NMR (D2O, ppm): -178.31 (PTA at -98.51 ppm
as reference).
2.3.1.6. Synthesis of [Ag2(- 4-Cl-pz)2(PTA)2] [2.6]
This complex was prepared by the same procedure as 2.1, using [Ag(4-Cl-pz)]n polymeric
precursor and 2 equivalents of PTA. X-ray quality crystals were obtained by the slow evaporation
of reaction solution.
2.3.1.7. Synthesis of [Ag2(- 4-CH3-pz)2(PTA)2] [2.7]
This complex was prepared by the same procedure as 2.1, using [Ag(4-CH3-pz)]n polymeric
precursor and 1 equivalent of PTA. X-ray quality crystals were obtained by the slow evaporation
of reaction solution.
2.3.1.8. Synthesis of [Ag2(- 3-CH3-pz)2(PTA)2] [2.8]
This complex was prepared by the same procedure as 2.1, using [Ag(3-CH3-pz)]n polymeric
precursor and 1 equivalent of PTA. X-ray quality crystals were obtained by the slow evaporation
of reaction solution.
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2.3.2. X-ray data collection and structure refinement
Colorless block-shaped crystals of all complexes (2.1-2.8) were obtained by recrystallization
through diffusion of hexanes into their dichloromethane (CH2Cl2) solutions and/or slow
evaporation of the reaction solution. In all cases a suitable crystal was selected and mounted on a
Bruker D8 Quest diffractometer equipped with PHOTON 100 detector operating at T = 298 K.
Data were collected with shutter less scan technique using graphite monochromated Mo-Kα
radiation (λ = 0.71073 Å). The total number of runs and images for data collection was based on
strategy calculation from the program APEX3 (Bruker). Resolution of  > 26° was achieved in all
cases. Cell parameters were retrieved using the SAINT (Bruker) software and refined using SAINT
(Bruker). Data reduction was performed using the SAINT (Bruker) software, which corrects for
Lorentz and polarization effects. The final completeness is 95.3% (2.1), 99.7% (2.2), 99.6% for
(2.3), 99.4% (2.4) 99.2% (2.5), 99.7% (2.6), 99.7 % (2.7) and 99.2 % (2.8). Multi-scan absorption
corrections were performed on all data sets using SADABS 2016/2. The minimum and maximum
transmissions for 2.1 are 0.685 and 0.746, for 2.2 are 0.695 and 0.745, for 2.3 are 0.646 and
0.745, for 2.4 are 0.685 and 0.745 and for 2.5 are 0.646 and 0.745 for 2.6 are 0.399 and 0.745, for
2.7 are 0.685 and 0.745 and for 2.8 are 0.643 and 0.745 respectively. The structures for
complexes 2.1-2.4 were solved in the space group P-1 (No. 2), for complexes 2.5 and 2.6 in C2/c
(No. 15) and for complexes 2.7 and 2.8 by P21/n (No. 11) by intrinsic phasing using the ShelXT
(Sheldrick, 2015)18 structure solution program and refined by full matrix least square procedure
on F2 using version 2016/6 of ShelXL.19 The non-hydrogen atoms were refined anisotropically in
all cases. Hydrogen atom positions were calculated geometrically and refined using the riding
model. For structures of complexes 2.1, 2.3, 2.5, 2.6, 2.7 and 2.8 only half of the molecule is
present in the asymmetric unit, with the other half consisting of symmetry equivalent atoms. To
alleviate the complications related to solvent accessible voids within the extended lattice of
complex 2.2, the SQUEEZE operation (included in the PLATON program) was performed with
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the raw data set and the structure was refined form the data obtained upon SQUEEZE operation.20
For the complex 2.6, solvent accessible voids were masked in Olex2 by solvent mask operation.21
Despite of several attempts, in case of 2.4, an accurate position of the hydrogen atoms for the
lattice water molecules was not achieved. Therefore, no hydrogen is added on those oxygen
atoms. All calculations and molecular graphics were preformed using either SHELXTL 2014 or
Olex221 programs. Crystal data and structure refinement parameters for compounds 2.1-2.5 are
listed in Table 2.1 and 2.6-2.8 are listed in appendices Table A2.1. CCDC 1825643 (complex
2.1), CCDC 1825644 (complex 2.2), CCDC 1825646 (complex 2.3), CCDC 1825647 (complex
2.4) and CCDC 1825645 (complex 2.5) contain the supplementary crystallographic data for this
paper. Complexes 2.6, 2.7 and 2.8 have not been deposited yet.
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Table 2.1. Crystal data and structure refinement parameters for complexes 2.1-2.5
Formula

C78H64Ag2N4Cl2P4 C60H49Ag2N4Cl2P3 C78H64Ag2N6O4P4

C60H57Ag2N6O8P3

C30H52Ag2N16Cl2P4

Dcalc./ g cm-3

1.434

1.335

1.443

1.374

1.722

/mm-1

0.80

0.86

0.72

0.76

1.31

Formula Weight

1467.85

1205.58

1488.97

1298.70

1047.39

Color

Colorless

Colorless

Colorless

Colorless

Colorless

Shape

Block

Block

Block

Block

Block

T/K

298(2)

298(2)

298(2)

298(2)

298(2)

Crystal System

Triclinic

Triclinic

Triclinic

Triclinic

Monoclinic

Space Group

P-1

P-1

P-1

P-1

C2/c

a/Å

12.3970(7)

11.9900(6)

12.4684(8)

12.0477(6)

22.3522(18)

b/Å

12.6513(7)

13.4064(7)

12.7646(9)

13.9333(6)

7.6984(6)

c/Å

13.4150(7)

20.5531(11)

13.4383(10)

20.1754(10)

25.899(2)

α/°

97.372(2)

93.164(2)

98.117(2)

81.223(1)

90

/°

116.099(1)

93.563(2)

116.230(2)

84.884(1)

114.962(1)

/°

108.552(2)

114.083(1)

108.435(2)

68.853(1)

90

V/Å3

1700.01(16)

2998.6(3)

1714.0(2)

3119.5(3)

4040.2(6)

Z

1

2

1

2

4

Wavelength/Å

0.71073

0.71073

0.71073

0.71073

0.71073

Radiation type

Mo-Kα

Mo-Kα

Mo-Kα

Mo-Kα

Mo-Kα
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Table 2.1. Crystal data and structure refinement parameters for complexes 2.1-2.5 (Continued)
Formula

C78H64Ag2N4Cl2P4

C60H49Ag2N4Cl2P3

C78H64Ag2N6O4P4

C60H57Ag2N6O8P3

C30H52Ag2N16Cl2P4

min/°

6.00

6.00

5.80

5.80

6.20

max/°

56.60

52.80

53.00

52.60

52.80

Measured Refl.

28423

55827

31251

57586

38314

Independent Refl.

8045

12266

7051

12623

4113

Reflections Used

6244

8456

5461

10176

3876

Rint

0.032

0.043

0.051

0.024

0.019

Parameters

406

622

424

712

244

a

GOF

1.050

1.040

1.070

1.040

1.190

c

wR2

0.083

0.107

0.154

0.129

0.073

0.037

0.045

0.058

0.039

0.029

b

R1

aGOF = [[(Fo2-Fc 2)2]/(No-Nv)]1/2 (No = number of observations, Nv = number of variables).
R1 = Fo-Fc/Fo. cwR2 = [((Fo2-Fc2)2/Fo2)]1/2

b
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2.3.3. Antibacterial experiment
A skin and soft tissue infection (SSTI) model was used to study the antibacterial properties of
three silver complexes. In this model, two layers of agar were employed to mimic a tissue
infection with a nutrient rich bottom and the soft-top layer to allow for even dispersal of bacteria.
The top soft agar acts like the skin and as bacteria grow they migrate towards the bottom nutrient
layer mimicking an infected tissue. Frozen samples of Pseudomonas Aeruginosa were thawed
and streaked on an agar plate. A single colony was selected and grown in Luria Broth (LB) for 18
h. The suspension was diluted with LB until an A600 (absorbance) of 0.5 was reached. The soft
agar bacterial suspension was prepared by adding 120 L of the above solution to 100 mL 0.8%
(w/v) agar with 1% NaCl, which had been autoclaved and cooled to 45 °C before addition. The
suspension was gently vortexed and 8 mL was spread evenly on the surface of 20 mL of a 1.5%
(w/v) TSB agar plate (100 x 15 mm2) and allowed to solidify. The plates were incubated for 2 h at
37 °C in order for the bacteria to reach log phase before bactericidal experiments were performed.

2.4. Results and discussion
In most cases the solution structure of coordination complexes with substitutionally labile ligands
(like PPh3 and PTA in the present case) is different from the solid-state structure. Therefore, we
have chosen to perform 31P NMR studies with complexes 2.1-2.5, to gain an insight on possible
solution characteristics of these complexes. Due to difference in solubility,

31

P NMR

spectroscopy for complexes 2.1-2.4 was performed in CDCl3 solutions, while the same for
complex 2.5 was carried out in D2O (due to poor solubility in CDCl3 or CD2Cl2). For the former
complexes PPh3 was used as standard and PTA has been employed for the latter one. The
substantial kinetic lability of the phosphine ligands often leads to rapid ligand exchange in
solution at ambient temperature at the NMR time scale. Indeed, 31P NMR spectra recorded in the
275 – 295 K temperature range for the complexes uniformly reveal one resonance indicating the
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fluxional behavior in solution resulting in convergence of the two magnetically inequivalent PPh 3
ligands for complexes 2.2 and 2.4. The comparative 31P NMR spectra are shown in Figure 2.1 and
the chemical shift values are listed in the experimental section. The room temperature 1H NMR
spectra of 2.2 and 2.4 also show a single resonance for the pyrazole H3 and H5 protons, in
agreement with the 31P NMR results.

Figure 2.1. Comparative 31P NMR spectra for complexes 2.1-2.5. (1 corresponds to 2.1 and so on)
Single crystal X-ray crystallographic analyses reveal the molecular structures for all complexes
(2.1-2.8). Among them the perspective view for three structures (2.1, 2.2, 2.5 and 2.6) are
depicted in Figures 2.2 and 2.3 and selected metric parameters are listed in Tables 2.2 and 2.3.
The X-ray structures and the metric parameters for complexes 2.3, 2.4, 2.7 and 2.8 are provided
in the Appendices as Figures A2.1, A2.2 and Tables A2.2, A2.3 for 2.3 and 2.4 and A2.4 for 2.6,
2.7, and 2.8 respectively.
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Figure 2.2. Perspective view of the molecular structure of complexes 2.1 (left) and 2.2 (right).
The thermal ellipsoids are shown at 35% probability level (H atoms are omitted and the labeling
scheme are shown only for the hetero atom for the sake of clarity). Color code: C, black; N, blue;
Cl, green; P, pink and Ag, yellow.

Figure 2.3. Perspective view of the molecular structure of complexes 2.5 (left) and 2.6 (right).
The thermal ellipsoids are shown at 35% probability level (H atoms are omitted and the labeling
scheme are shown only for the hetero atom for the sake of clarity). Color code: C, black; N, blue;
Cl, green; P, pink and Ag, yellow.
X-ray structures of complexes 2.1, 2.3, 2.5, 2.6, 2.7 and 2.8 (Figs 2.2(left), A1 (left), 2.3 (left),
2.3 (right), A2.2 (left) and A2.2 (right) respectively) reveal that in all six cases the two Ag(I)
centers are equivalent and each metal center for 2.1, 2.3 and 2.5 resides in a distorted tetrahedral
coordination environment. To assess the distortion from the ideal tetrahedral geometry around the
Ag centers, a simple index (4) developed by Houser and co-workers22 have been calculated for
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2.1 and 2.5. Simple index is unity for a perfect tetrahedron and zero for square planar geometry.
The 4 values for 2.1 and 2.5 are 0.89 and 0.78 respectively suggesting the coordination
environment around the Ag centers is distorted tetrahedral in these complexes. Two -pyrazolates
bridge the Ag(I) centers and the other two coordination sites of each Ag(I) center are occupied by
two PPh3 ligands. The two Ag atoms along with four N atoms (Ag1, Ag1a, N1, N2, N1a, N2a) of
the bridging pyrazolates form a centrosymmetric six-membered ring in a chair conformation, with
one Ag-atom on either side of the planes defined by the pz rings and at a Ag…Ag distance of
4.209(4) Å (2.1) and 4.205(3) Å (2.5). This twisted metallacyclic conformation is rare in
literature, but not unprecedented.23 Although 2.1 and 2.5 are structurally similar, careful scrutiny
of the metric parameters reveals certain differences (Table 2.1): The average Ag−N bond length
in 2.1, 2.319(2) Å, is shorter than that in 2.5 (2.367(3) Å); The P−Ag−P angle in 2.1, 118.82(2)°,
is noticeably more acute than the corresponding 140.43(3)° angle in 2.5 and the same applies to
the N−Ag−N bond angles, 98.00(7)° (2.1) and 103.37(9)° (2.5), the differences attributed to the
steric bulk of PTA compared to PPh3. Consequently, the average N1−Ag1−P1 angle in 2.1
109.32(6)° is more obtuse than in 2.5 101.80(7)°. The average Ag1−P1 bond lengths for these
two complexes, 2.4921(7) Å (2.1) and 2.4972(8) Å (2.5), respectively, are indistinguishable.
Table 2.2. Selected bond distances (Å) and angles (°) for 2.1 and 2.5.
Complex 2.1

Complex 2.5

Ag1−P1

2.5003(7)

2.5345(8)

Ag1−P2

2.4838(7)

2.4598(7)

Ag1−N1

2.285(2)

2.336(2)

Ag1−N2a

2.353(2)

2.398(3)

P2−Ag1−P1

118.82(2)

140.43(3)

N1−Ag1−P2

110.20(6)

109.52(7)

37

Complex 2.1

Complex 2.5

N1−Ag1−P1

115.09(6)

100.00(7)

N1−Ag1−N2a

98.00(7)

103.37(9)

N2a−Ag1−P2

105.32(6)

105.46(7)

N2−Ag1−P1

106.68(6)

92.23(7)

The a-labeled atoms are generated by the −x+1, −y, −z+1 symmetry operation
The crystal structure of 2.2 reveals an unsymmetrical dinuclear complex (Fig. 2.2). In this case,
the coordination geometry of one Ag(I) center is distorted tetrahedral, whereas that of the other
Ag(I) center is approximately triangular planar.
Table 2.3. Selected bond distances (Å) and angles (°) for 2.2
Complex 2.2
Ag1−P1

2.4852(9)

Ag2−P3

2.3735(11)

Ag1−P2

2.4751(9)

Ag2−N4

2.204(3)

Ag1−N1

2.260(3)

Ag2−N2

2.246(3)

Ag1−N3

2.361(3)

P2−Ag1−P1

121.03(3)

N4−Ag2−P3

130.82(9)

N1−Ag1−P2

121.43(8)

N4−Ag2−N2

108.63(12)

N1−Ag1−P1

107.29(8)

N2−Ag2−P3

120.06(8)

N1−Ag1−N3

95.28(11)

N3−Ag1−P2

102.40(8)

N3−Ag1−P1

104.14(8)
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In 2.2, the average Ag−N bond length of 2.311(3) Å at the tetrahedral site is comparable to the
corresponding distance in 2.1, while that of the trigonal planar site, 2.225(3) Å, is considerably
shorter. The P1−Ag1−P2 angle (tetrahedral site) of 121.03(3)º, and the N1−Ag1−N3 angle of 2.2
(95.28(11)°) are comparable to the corresponding values in complex 2.1. However, the
N4−Ag2−N2 angle is noticeably larger 108.63(12)°, consistent with the planar coordination
sphere around Ag2 center. A structurally similar complex as 2.2 derived from unsubstituted
pyrazole, namely, [Ag2(-pz)2(PPh3)3] has been reported earlier.24 In this case the Ag−N bond
length at the tetrahedral and the triangular planar sites are 2.309(2) and 2.206(2) Å, respectively,
comparable to the values observed in complex 2.2. The bond angles for both tetrahedral and the
planar sites in [Ag2(-pz)2(PPh3)3] and complex 2.2 are rather similar. The Ag…Ag distance in
2.2 is 3.707(3) Å almost identical with that in [Ag2(-pz)2(PPh3)3] (3.706(1) Å).
Complex 2.3 (Fig A1 (left)) is structurally quite similar to complex 2.1 (Fig 2 (left)). The two Ag
atoms in this structure also form a twisted metallacycle as observed for 2.1. In this case the
Ag…Ag distance is 4.305(4) Å. The average Ag−N bond length in 2.3, 2.343(4) Å is similar to
that in 2.1 (2.319(2) Å). The P−Ag−P angle in 2.3, 120.75(4) is consistent with that found in 2.1
(118.82(2)°). The two Ag atoms in 2.4 (Fig A1 (right)) exhibit same coordination geometry as in
complex 2.2 (Fig 2(right)). In 2.4, the average Ag−N bond length of 2.364(3) Å at the tetrahedral
site, slightly longer than the corresponding distance in 2.2, while that of the trigonal planar site,
2.233(3) Å, is very similar. The P1−Ag1−P2 angle (tetrahedral site) is 24.62(3)º and the
N1−Ag1−N4 angle in 2.4 (97.24(11)°) are comparable to the corresponding values in complex
2.2. Ag1–P1 bond distances of complexes 2.6, 2.7 and 2.8 are quite similar i.e. 2.3630 (12),
2.3618 (19) and 2.3654 (13) respectively (Table A4). In all three cases both silver metals have
distorted trigonal planar geometry with N1-Ag-N2 angles 107.47(13) for 2.6, 108.3(2) for 2.7 and
108.48(12) for 2.8.
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2.4.1. Antibacterial studies
Blank KBr pellets (typically utilized for recording IR spectra) and KBr pellets with 2% (w/w) of
three complexes (2.1, 2.2 and 2.5), each weighing between 34 and 46 mg, were evenly mulled
and pressed with a two-ton load. Three blanks, containing PTA, or 4-Cl-pzH, or PPh3, were also
prepared in the same manner. Pellets were carefully placed on the plates (see Experimental
section for preparation) after 2 h of incubation at 37 °C. Visible circular zones of bacterial
clearing (zone of inhibition) around complex 2.5 and AgNO3 pellets were observed after
incubation at 37 °C for 18 h (Figure 2.4). Complex 2.5 and AgNO3 pellets revealed comparable
bacterial clearance even though the KBr pellet with complex 2.5 contained less silver per weight
than the AgNO3 pellet. This superior growth inhibitory performance of 2.5 could in part be due to
marginal antibacterial effects of ligands (PTA and 4-Cl-pzH), which showed much smaller but
still visible zones of bacterial growth inhibition. The plates containing complexes 2.1 and 2.2
exhibited minimal bacterial clearance while PPh3 and KBr (bottom row) showed no zone of
inhibition. Also the % of Ag(w/w) and concentration of bio-active silver in plates a), b), e) and f)
are listed in Table 2.4.

Figure 2.4. P. aeruginosa lawns after 18 h incubation with pellets of 2% (w/w) of a) complex 2.5,
b) AgNO3, c) PTA, d) 4-Cl-pzH, e) complex 2.1, f) complex 2.2, g) PPh3, and h) blank plate.
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The antibacterial efficacy is highly dependent on efficient cellular uptake of the compound. A
slightly electronegative surface potential of bacterial cell walls allow cationic complexes to
penetrate relatively easily compared to their neutral analogues.25 In the present study all silver(I)
complexes are neutral and thereby are lacking this advantage, as can be seen from the marginal
antibacterial effects of complexes 2.1 and 2.2 (Figure 2.4). However exceptional growth
inhibition of P. aeruginosa by complex 2.5 can be attributed to enhanced cellular uptake of this
complex facilitated by the PTA moieties due to their optimal lipophilicity. The bridgehead N
atoms of the PTA moiety become protonated under certain physiological conditions15 and can
thereby contribute towards facile cellular uptake and thereafter retention of its complexes. In fact,
the adamantane motif has been widely used in various pharmaceuticals as a “lipophilic bullet”
and these drugs are generally very effective due to rapid internalization by a variety of cells and
tissues.26 Although a few silver complexes containing the PTA moiety have shown promise as
antibacterial agents, they are relatively sparse.27 It is interesting to note that the majority of AgPTA compounds are polymeric and their bridgehead N atoms also engage in bonding with
silver.26-27 Our present report describes a new discrete dinuclear silver pyrazolate complex, where
PTA is directly coordinated to Ag(I) centers and no further polymeric growth through the N
atoms of the PTA moiety has been realized.
Table 2.4. Concentration and %Ag (w/w) in each pellet.
Sample

Conc. of Ag in the pellet (M)

% Ag in the pellet (w/w)

2.1

1.03548 x 10-6

0.29394

2.2

1.26075 x 10-6

0.35789

2.5

1.45127 x 10-6

0.41197

AgNO3

4.47401 x 10-6

1.27003

41

A previously developed soft tissue infection (SSTI) model has been utilized for the present
antibacterial studies.28 This model mimics the skin in which steady penetration of bacteria to the
deeper layer has been achieved using a two-layer agar system that has a soft, evenly dispersed
bacterial lawn on the top and a nutrient-rich bottom layer. The gradient causes the bacteria to
slowly travel from the slender top layer to the nutrient-rich bottom layer, much alike what would
occur in a typical skin infection.
Three complexes (2.1, 2.2 and 2.5) along with 4-Cl-pzH and two the phosphine ligands (PPh3 and
PTA) have been assessed for their bactericidal efficacy against a Gram-negative aerobic gammaproteobacterium namely, P. aeruginosa. This bacterium is one of the most notorious contributors
to the nosocomial infections around the World.29 During pre-penicillin G era, Staphylococcus
aureus used to be the most common pathogen responsible in burn wound infections. Although
this Gram-positive bacterium still remains one of the sources for such infections, in recent times
P. aeruginosa has been recognized as major cause of burn wound infections in hospitals. 30 Apart
from P. aeruginosa, fatal burn wound sepsis can also be instigated through infections caused by S.
aureus and A. Baumannii.31 However, a very recent study revealed that P. aeruginosa infections
have the most severe consequences towards burn injuries and often lead to mortality. 32 In the
same study, the effect of the burn wound exudates from a group of patients has been investigated
on virulence of several pathogens (including S. aureus and A. Baumannii). Interestingly among
all the pathogens, P. aeruginosa exclusively exhibits normal proliferation within these exudates.
In contrast, kinetic studies clearly delineated growth inhibitory effect of the burn wound exudates
for other pathogens.32 Development of therapeutics to combat this nosocomial pathogen deserves
urgent attention as with time these microorganisms have developed increasing resistance to
antibiotics, particularly in immunocompromised and cystic fibrosis patients.29
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Silver nitrate and silver sulfadiazine (SSD) are two widely used topical antimicrobial agents for
burn wound infections. However, these topical therapeutics suffer from serious limitations: Rapid
reaction of silver nitrate with biological chloride ions forms insoluble silver chloride and thereby
requires continuous administration with the occlusive dressings. Also, although dissociation of
silver ions from of SSD is slower compared to that in silver nitrate, poor dermal penetration of
this topical agent limits its efficacy on severe burn wound sites. Moreover, a nephrotic syndrome
is prevalent within patients receiving this topical therapy, due to an allergenic reaction associated
with the sulfadiazine component.29,

33

These considerations encouraged us to assess the

effectiveness of the silver pyrazolate complexes as alternative topical therapeutics against P.
aeruginosa infections utilizing a SSTI model. The lability of Ag-P bonds, as discussed in detail
earlier by other research groups,24 is also evident from the NMR spectroscopic behavior of the
present Ag(I) complexes. Such lability induces the release of bioactive Ag to the wound sites and
is believed to be a contributing factor towards the antibacterial activity of complexes 2.1, 2.2 and
2.5 in the present work.

2.5. Conclusions
In conclusion eight dinuclear silver(I) complexes (2.1-2.8) derived from two 3 and 4-subsitutued
pyrazole ligands have been synthesized and structurally characterized. The highly water-soluble
complex 2.5 incorporating a PTA coligand has shown excellent antibacterial activity in SSTI
model against P. aeruginosa. Antibacterial sctivity of 2.6-2.8 is under study. The zone of
inhibition (could be either bactericidal or bacteriostatic) in the bacterial culture caused by
application of complex 2.5 is superior to that for AgNO3. The 4-Cl-pzH ligand shows marginal
growth inhibition, in line with the known antimicrobial properties of pyrazoles. The relatively
lower efficacy of the two organosoluble complexes (2.1 and 2.2) is tentatively attributed to
inferior cellular uptake (considering all these complexes are neutral in charge). The highly
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lipophilic nature of the PTA motif (in case of 2.5) overwhelms the disadvantage of its complex
being neutral, which is considered unfavorable towards cellular internalization compared to a
positively charged analogue. Silver-based nanoscale antibacterial agents have also been projected
as new generation chemotherapeutics to combat antibiotic resistance. However, the toxicity
profile of these nanomaterials towards human health and environment is debatable and extensive
in vitro and in vivo studies are warranted to understand their transport and fate.34 Therefore, the
urge for the development of discrete molecular Ag-based antibacterial agents remains highly
relevant in treating most notorious classes of pathogens that are becoming resistant to a variety of
antibiotics. Though there have been persistent efforts within the related research community to
develop Ag(I)-based antimicrobial agents, such studies with Ag(I) pyrazolate complexes is
relatively sparse. The majority of the biomedical studies have, so far, involved either Ag(I)-based
coordination polymer/MOF or hybrid materials.35 In one of such studies Ag(I) bipyrazole-based
coordination polymers were employed to assess the antibacterial activity against E.Coli, P.
aeruginosa and S. sureus.35
In the present case, we have described a rare experimental venture of assessing the antimicrobial
potency of a class of discrete Ag(I) pyrazolate complexes.

Complex 2.5 is particularly

highlighted in our antibacterial experiments due to the biocompatible nature of its constituents.
Further antibacterial study of 2.5 and other water-soluble complexes is in progress. Several
pyrazole-based NSAIDs are already approved for clinical use and PTA has been part of several
Ru-based anticancer agents.14
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3.1. Abstract
Five pyrazole-based tripodal ligands, compounds 3.1 – 3.5, based on a 1,3,5-triethylbenzene
scaffold, show aggregation-induced emission enhancement (AIEE) and their application as
fluorescent probes for nitroaromatics has been investigated. All five compounds are weakly
fluorescent in THF, but their fluorescence intensity increases with the addition of a poor solvent
(water), causing nanoaggregation, as confirmed by changes in UV-vis and emission spectra, and
light scattering techniques. The nanoaggregates exhibit time-dependent emission characteristics
and can serve as sensors for the detection of nitroaromatic compounds. The selective detection of
picric acid (PA) over other nitroaromatic compounds by 3.1-3.3 is attributed to the photoinduced
electron transfer from the trispyrazole to the quencher, as confirmed by TD-DFT calculations.
Furthermore, these compounds were tested towards sensing of PA in the vapor and solid phases
by means of changes in emission spectra observable by naked eye. The supramolecular
assemblies of 3.1 and 3.3 with PA have been structurally characterized by X-ray crystallography.

3.2. Introduction
Materials displaying aggregation induced emission (AIE; an intense emission in the aggregated or
solid state, but weak or no luminescence in solution)1, or aggregation induced emission
enhancement (AIEE; emission of a chromophoric material enhanced by aggregate formation) 2
have attracted much interest over the past decade because of their applications in optoelectronics3,
fluorescent probes4, and biosensors5. Both phenomena are opposite to the phenomenon of
aggregation caused quenching (ACQ) of common organic chromophores, the result of high
concentration or π - π stacking interaction, which limits their application potential6. Since the
recognition of AIE in 2001 by Tang and co-workers, researchers have been pursuing the
development and applications of materials with AIE characteristics7. Up to date, numerous
AIE/AIEE active organic compounds, such as siloles8, tetraphenylethene (TPE) derivatives9,
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naphthalimide10, carbazole11, boron-dipyrromethene (BODIPY) derivatives12, pyrene13, Schiffbase14 and triphenylamine-based compounds have been documented15. Several mechanisms have
been proposed for the AIE phenomenon, such as restriction of intramolecular rotations (RIR) 16,
twisted intermolecular charge transfer (TICT)17, J-aggregate formation18, excited-state
intramolecular proton transfer (ESIPT)19, photoinduced electron transfer (PET)20 and C=N
isomerization21. Concurrently with the above developments, much attention has been focused on
the sensing of explosives, which besides presenting safety and security risks, are also potent
environmental contaminants22, being highly toxic and/or mutagenic to humans and other
organisms23. Nitrotoluenes, such as 2-nitrotoluene, 4-nitrotoluene, dinitrotoluenes and
trinitrotoluenes, are examples of microorganism secondary metabolites released in the
environment. However, industrial chemicals, such as dyes, explosives, solvents and insecticides,
contribute the majority of nitroaromatic environmental contaminants24.
The latter (industrial chemicals) are recalcitrant contaminants that persist in the environment even
after biological treatment. Therefore, the development of efficient sensors to detect nitroaromatics
at low concentrations is highly desirable in order to prevent terrorist threats, as well as detect
environmental pollution25. Among the various analytical techniques, fluorescence sensing offers
high sensitivity, simplicity, low background noise, low cost, as well as on-site workability26. In
addition, AIE exhibiting materials offer more diffusion channels for the exciton to migrate and,
therefore, be faster annihilated by the nitro explosives27. Taking advantage of these effects,
emission signals promoted by AIEE dyes in the presence of nitro explosives offer a promising
platform for the development of an optical sensor28. Tripodal receptors can form complexes with
cations and anions, where the size of cavity, flexibility and hardness of donor atoms are the main
factors determining their binding selectivity29, which can be further fine-tuned by chemical
modification of pendant arms, e.g., shape, size, chain length, donor atoms30. The design and
development of tripodal ligands to selectively recognize a specific analyte has encouraged
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considerable research activity, becoming a significant field of supramolecular chemistry31. Along
these lines, we herein report five tripodal trispyrazole compounds, 3.1– 3.5, having AIEE
properties, along with the study of their properties as fluorescence sensors for nitroaromatic
compounds. Picric acid (PA) is a primary constituent of explosives in landmines and serves as
model compound for studies of explosives21, 32. To the best of our knowledge, this is the first
report on tripodal pyrazole-based compounds exhibiting AIEE properties and their use in the
detection of PA in the solid, liquid and vapor phases.
Caution! Picric acid, a polynitroaromatic compound, is a powerful explosive. It must be handled
with care, and in small quantities.

3.3. Experimental
3.3.1. Materials and methods
All chemicals were purchased from Sigma-Aldrich, Alfa Aesar or Fisher Scientific Co., and used
as received. Reagent grade solvents were used without further purification. 1,3,5tris(bromomethyl)-2,4,6-triethylbenzene33 and 4-phenyl-1H-pyrazole34 were synthesized by
literature procedures. 4- (3- chlorophenyl)-1H- Pyrazole and 4- (4- nitrophenyl)-1H- Pyrazole
were synthesized similarly to 4-phenyl-1H-pyrazole34 but, using the 3-chloro-phenylacetic acid
and 4-nitro-phenylacetic acid, respectively. The 1H-NMR spectra were recorded on a 400 MHz
Bruker Avance spectrometer. FT-IR spectra were recorded with an Agilent Cary 600 FTIR.
Elemental analyses were carried out by Galbraith Laboratories, Inc., Knoxville, TN, USA.
Electronic absorption spectra were recorded on an Agilent Cary 5000 UV-vis-NIR
spectrophotometer using 1 cm path length cuvette. Emission spectral studies of solutions and
ﬂuorescent test strips were carried out using an Agilent fluorometer using an excitation and
emission bandwidth of 2.5 nm. The ﬂuorescent test strips were prepared by dip coating of
trispyrazole compounds, followed by air drying. The morphology of the nano-aggregates was

52

studied by dynamic light scattering spectroscopy using Carl Zeiss. The SEM images were
recorded with a TESCAN VEGA3 instrument using a SE detector and equipped with an EDAX
energy-dispersive X-ray spectroscopy (EDX) detector. HPLC grade THF and double distilled
water were employed in all spectral measurements. Freshly prepared sample solutions were used
for each measurement.
Frequency-domain fluorescence lifetime measurements were performed using a ChronosFD
spectrofluorometer (ISS, Champaign, IL). Samples were excited with a 280 nm modulated diode,
and emission was collected using 305 nm long-pass filters (Andover, Salem, NH). All
measurements were conducted at room temperature in quartz cells. Modulation-phase data were
analyzed using GlobalsWE software, and the χ2 parameter was used as goodness-of-fit criterion.
The average intensity decay lifetime was obtained by fitting the data to a multiple-exponential
decay model.
X-ray diffraction data were collected with Bruker D8 Quest diffractometer. Colorless single
crystals of 3.1-3.5 and ligand-PA compounds were obtained by recrystallization from organic
solvents such as acetone and/or dichloromethane. A suitable crystal for each compound was
selected and mounted on a Mitegen loop using Parabar oil on a Bruker D8 Quest CMOS
diffractometer. The crystal was kept at room temperature during data collection. Using APEX3,
the structure was solved with the ShelXT35 structure solution program, using the intrinsic phasing
method. Using Olex236, the model was refined with version 2016/6 of ShelXL37 using full matrix
least squares on F2 minimization. A multi-scan absorption correction was performed using
SADABS-2016/2 (Bruker, 2016/2) was used for absorption correction. All non-hydrogen atoms
were refined anisotropically. Hydrogen atom positions were calculated geometrically and refined
using the riding model, but some hydrogen atoms were refined freely. Disordered solvent
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electron densities were removed using SQUEEZE routine (PLATON)38 or Solvent MASK
(Olex2)36 from compounds [3.5] and [3.3]-PA(1:2).
3.3.1.1. Synthesis of Tris-(4-Ph-pz); (C42H42N6) [3.1]
A round bottom flask was charged with NaOH (250 mg), 4-(phenyl)-1H-pyrazole (385 mg; 1.75
mmol) and 15 mL of dimethylforamide (DMF) and the reaction mixture was stirred for 40 min.
1,3,5-tris(bromoethyl)-2,4,6-triethyl benzene (220 mg; 0.5 mmol) was added, the reaction mixture
was heated for 36 h at 70 °C and the hot contents of the flask were poured into 50 mL cold water;
the white, spongy solid that formed was refrigerated overnight. The white product was filtered out
under suction and washed with water, followed by diethylether. Finally, the compound was redissolved in the minimal volume of dichloromethane, crushed out by hexane and dried. Yield:
284 mg (90 %). Molecular weight: 630.84 g/mol. 1H-NMR (ppm, DMSO-d6): 0.88 (9H, t, CH3);
2.87 (6H, q, CH2); 5.54 (6H, s, CH2); 7.16 (3H, t, phenyl); 7.29 (6H, t, phenyl); 7.51 (6H, d,
phenyl); 7.89 (3H, s, pz); 7.96 (3H, s, pz). IR (ʋmax cm-1): 3060(w), 2976(w), 1658(w), 1608(w),
1564(m), 1491(w), 1456(w), 1554(w), 1367(m), 1336(m), 1298(w), 1228(w), 1176(s), 1068(w),
994(s), 952(s), 752(s), 688(s), 583(w). Elemental analysis; found (%) C = 79.79, H = 6.35, N =
13.31; calculated (%) C = 79.97, H = 6.71, N = 13.32. X-ray quality single crystals were grown
by slow evaporation from acetone or dichloromethane solutions.
3.3.1.2. Synthesis of Tris-4-(3-Cl-Ph-pz); (C42H39N6Cl3) [3.3]
Similarly to the synthesis of 3.1, but, using 4-(3-Cl-Ph)pzH (312 mg; 1.75 mmol) as a pyrazole;
Yield: 327 mg (89%). Molecular weight: 734.17 g/mol. 1H-NMR (ppm, CDCl3): 1.02 (9H, t,
CH3); 2.82 (6H, q, CH2); 5.50 (6H, s, CH2); 7.16 – 7.24 (9H, m, phenyl), 7.37 (3H, s, phenyl) ;
7.33 (3H, s, pz) 7.81 (1H, s, pz). IR (ʋmax cm-1): 3109(w), 2979(w), 1679(w), 1604(s), 1568(m),
1465(m), 1351(m), 1179(s), 1078(m), 1067(s), 993(m), 858(s), 771(s), 666(s), 588(m).
Elemental analysis for the Tris [4-(3-Cl-Ph)-pz] found (%) C = 67.55, H = 5.52, N = 11.12;
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Calculated (%) C = 67.07, H = 5.49, N = 11.17. X-ray quality crystals were grown by slow
evaporation from an acetone solution.
3.3.1.3. Synthesis of Tris-4-(4-NO2-phenyl-pz); (C42H39N9O6) [3.4]
Similarly to the synthesis of 3.1, but, 4-(4-NO2-Ph)pz (332 mg; 1.75 mmol) as a pyrazole; Yield:
325 mg (85%). Molecular weight: 765.83g/mol. 1H-NMR (ppm, CDCl3): 1.05 (9H, t, CH3); 2.84
(6H, q, CH2); 5.53 (6H, s, CH2); 7.51 (6H, d, phenyl); 8.12 (6H, d, phenyl); 7.53 (3H, s, pz); 7.89
(3H, d, pz). IR (ʋmax cm-1): 3115(w), 2977(m), 1672(w), 1598(s), 1589(m), 1500(s), 1442(w),
1330(s), 1227(m), 1194(m), 1110(s), 1069(m), 994(m), 952(s), 846(s), 753(s), 693(m), 590(m).
Elemental analysis for the TPZ [4-(4-NO2-Ph)-pz] (C42H39N9O6) was found (%) C = 62.50, H =
5.08, N = 15.51; Calculated (%) C = 62.91, H = 5.41, N = 15.72. X-ray quality single crystals
were grown by slow evaporation from acetone or dichloromethane solution.
3.3.1.4. Synthesis of Tris-(4-I-pz) (C24H27N6I) [3.5]
Similarly, to the synthesis of 3.1, but, using 4-(iodo)-1H-pyrazole (339 mg; 1.75 mmol) as a
pyrazole; Yield: 351 mg (90%). Molecular weight: 780.24g/mol. 1H-NMR (ppm, CDCl3): 0.93
(9H, t, CH3); 2.71 (6H, q, CH2); 5.43 (6H, s, CH2); 7.07 (3H, s, pz); 7.55 (3H, s, pz). IR (ʋmax cm1

): 3066(w), 2974(w), 1678(w), 1574(w), 1507(w), 1456(m), 1416(m), 1276(m), 1160(m),

1112(m), 989(s), 938(s), 843(s), 793(s), 762(m), 718(m), 645(m), 604(s), 569(m). Elemental
analysis for the tris(4-I-pz) [C24H27N6I] was found (%) C = 36.47, H = 3.52, N = 10.45;
Calculated (%) C = 36.95, H = 3.49, N = 10.77. X-ray quality single crystals were grown by slow
evaporation from dichloromethane solution.
3.3.1.5. Synthesis of [3.1](PA) (C48H43N9O7)
31.5 mg (0.05 mmol) T(4-Ph)pz and 11.4 mg (0.05 mmol) were dissolved in 7 mL CHCl3 or
acetone and stirred 10 minutes at room temperature. Yield: 30 mg (70 %). 1H-NMR (ppm,
CDCl3): 1.06 (9H, t, CH3); 2.81 (6H, q, CH2); 5.53 (6H, s, CH2); 7.24-7.36 (18H phenyl+pz);
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7.30 (1H, s, -OHPA); 9.13 (2H, s, -CHPA) phenyl); 7.85 (3H, s, pz). X-ray quality golden yellow
colored single crystals were obtained by slow evaporation of the reaction solution.
3.3.1.6. Synthesis of [3.2] (PA)2 (C60H47Cl3N15O21)
7.8 mg (0.01 mmol) T-4-(4-NO2-Ph)pz and 6.8 mg (0.03 mmol) were dissolved in 7 mL CHCl3
and stirred 2 minutes at room temperature. Yield: 80 mg (68 %). 1H-NMR (ppm, CDCl3): 1.04
(9H, t, CH3); 2.82 (6H, q, CH2); 5.52 (6H, s, CH2); 7.23 – 7.38 (15H, m, phenyl + pz); 7.84 (3H,
s, pz); 7.36 (2H, s, -OHPA); 9.13 (4H, s, -CHPA). X-ray quality golden yellow colored single
crystals were obtained by slow evaporation of the reaction solution.
3.3.1.7. Synthesis of [3.1] (PA)3 (C63H51.5N16.5O24.5)
31.5 mg (0.05 mmol) T(4-Ph)pz and 33.4 mg (0.15 mmol) were dissolved in 7 mL CHCl3 or
acetone and stirred 10 minutes at room temperature. Yield: 50 mg (75 %). 1H-NMR (ppm,
CDCl3): 1.07 (9H, t, CH3); 2.81 (6H, q, CH2); 5.57 (6H, s, CH2); 7.23-7.36 (18H phenyl+pz);
7.38 (3H, s, -OHPA); 9.14 (6H, s, -CHPA) phenyl); 7.89 (3H, s, pz). X-ray quality golden yellow
colored single crystals were obtained by slow evaporation of the reaction solution.
3.3.2. Computational Details
Geometry optimization of the complexes of trispyrazole with one, two and three molecules of
picric acid have been performed using a density functional B97XD method developed by HeadGordon’s group,39 which includes a correction for dispersion, with the 6-31G* basis set. Next,
single point time dependent density functional theory (TD-DFT)40 calculations were carried out at
the optimized geometries to evaluate electronic excitation energies and oscillator strengths. All
electronic structure calculations were carried out using the GAUSSIAN 09 program package.41
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3.4. Result and discussions
All five pyrazole derivatives were synthesized in similar ways in an one-pot reaction, modifying a
published procedure33a, 33b, resulting in good, 80-90 % yields (Scheme 3.1). The synthesis and Xray crystal structure of compound 3.2 have already been reported elsewhere by some of us33b.
Each one of the five compounds has three pyrazole functionalities attached to the 2-, 4- and 6positions of a central 1,3,5-triethylbenzene ring via N-methylene bridges. Compounds 3.1, 3.3
and 3.4 crystallized in monoclinic, whereas 3.5 in orthorhombic crystal systems and compounds
3.1 and 3.3 in P21/n space group, while compounds 3.4 and 3.5 in P21/c and P212121 space
groups, respectively, with the whole molecule in the asymmetric unit. In the crystal structures of
compounds 3.1, 3.3 and 3.4, two pyrazolyl groups are on one side of the benzene ring plane and
the third pyrazolyl group along with all three ethyl groups are on the other. In compound 3.5,
however, two pyrazolyl and two ethyl groups lie on one side of the plane and the remaining one
pyrazolyl and one ethyl group on the other. All bond distances and angles are unexceptional.
Molecular structures of compounds 3.1 – 3.5 are shown in Figure 3.1.

Scheme 3.1. Synthetic scheme of five tripodal pyrazoles (3.1-3.5)
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Figure 3.1. Molecular structures of compounds 3.1 – 3.5 (1 to 5 respectively). Color code: black,
C; blue, N; red, O; green, Cl; purple, I.
The 1H-NMR resonances of 3.1, 3.3 – 3.5 are clearly resolved and consistent with threefold
molecular symmetry in solution (Table A3.1 and Figs. A3.1-A3.4). In their IR spectra, the weak
sp2(C-H) stretching vibration bands for all compounds occur in the 3060-3118 cm-1 range, the
weak to medium bands between 2974 cm-1 and 2979 cm-1 correspond to sp3(C-H) stretching
vibrations, while the aromatic C=C and C=N bands appear in the 1363-1679 cm-1 region (Figures
A3.5-A3.8).
Compounds 3.1 – 3.5 are soluble in common organic solvents, such as CH2Cl2, THF and acetone,
but insoluble in water, and are, therefore, convenient candidates to study aggregation in organic
solvents upon water addition.
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Figure 3.2. UV-vis absorption spectra of 3.1-3.5 in THF
The UV-vis absorption spectra of 3.1 –3.5 in THF (Fig. 3.2) show broad absorbance bands at
230-300 nm, assigned to π – π* transitions of the aromatic rings, which shifts to lower energy in
3.4. Upon water addition into the THF solution of 3.1 – 3.3, the absorbance decreases and λmax
redshifts from 255 nm (in THF) to 265 nm (in 70% water) (Figs. 3.3a and A3.9, A3.10). The
gradual levelling-off of the absorbance tail in the region of 500 nm and beyond, attributed to the
Mie eﬀ ect, confirms the formation of nanoparticle aggregates in these solvent mixtures 42. The
formation of nanoaggregates was further confirmed by a DLS study, which determined that
particles in the 100-250 nm size range were formed (Figs. A3.11-A3.13).

Figure 3.3. (a) UV – visible absorption spectral changes of 3.3 in THF with the addition of water
(0 to 90%). (b) SEM image of 3.3 in THF/H2O (30:70) mixture.
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SEM image of compound 3.3 in a 70% of aqueous mixture were also consistent with the
formation of such aggregates of irregular morphology (Fig. 3.3b). When the water content of the
mixture was raised to > 70%, the solution became turbid. Irradiation of the turbid THF/H 2O80/20 solution of 3.3 with a 365 nm lamp causes it to become blue luminescent (Fig. 3.4). Similar
observations were made with the other four compounds, 3.1, 3.2, 3.4 and 3.5.

Figure 3.4. Fluorescence spectral changes of 3.1 & 3.3 (15 µM) with the addition of water from 0
to 90% into THF.
In pure THF, compounds 3.1 – 3.3 are weakly fluorescent with λmax in the 310 – 330 nm range.
Importantly, their emission intensity is gradually enhanced upon stepwise addition of water, due
to the AIEE effect, caused by restriction of intramolecular rotation (RIR) 43. The fluorescence
spectra of 3.1 and 3.3 in water–THF mixtures with varying water content are shown in Fig. 3.4
(for 3.2 see Fig. A3.14). In a dilute solution, the free rotation of the peripheral phenyl rings
eﬀ ectively deactivates its excited species, hence only a faint emission is observed. However, the
formation of aggregates blocks the non-radiative relaxation channel, thereby activating radiative
decay44. Consequently, the emission intensity increases in the aggregated state. Obviously, a
notable AIEE effect was not observed for compound 3.5, which lacks peripheral phenyl rings.
Whereas the emission spectra of 3.1 and 3.3 were invariant with time, the intensity of the
emission of 3.2, monitored at 5 min intervals, steadily increased over a period of 30 min
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following the addition of H2O (Fig. A3.15). This effect is tentatively attributed to the larger
number of rotating phenyl rings of 3.2, compared to other compounds reported here45. The
emission lifetime of compound 3.2 is 1.2 ns in THF, but increases to 1.8 ns in 10:90 THF/H2O
mixture (Figs. A3.16 & A3.17), while the lifetimes of 3.1, 3.3, 3.4, and 3.5 are shorter than 1 ns
and were not determined. Addition of (viscous) ethylene glycol into THF solutions of 3.1 – 3.3,
caused their emission intensities to increase (Figs A3.18 & A3.19), consistent with the proposal
that the slowing down of rotations is responsible for this effect.
3.4.1. Sensor for nitroaromatic compounds
Because of the tripodal arrangement of N-sites available to act as H-bond acceptors, we
envisioned that compounds 3.1 – 3.5 might be good sensors for nitrophenols, picric acid in
particular. To study the recognition of nitrophenols and other nitroaromatics, a 3 x 10 -6 M
solution of PA was added stepwise to the suspension of nanoaggregates (THF/H2O 20/80%) of
3.1-3.3 (vide supra), causing initially an increase of the UV-vis absorbance (Figs. A3.20 &
A3.21), due to the formation of a ground state charge transfer complex46. The fluorescence
spectral changes accompanying PA addition to 3.1-3.3 were monitored (Figs. 3.5 & A3.22):
Quenching of fluorescence intensity with a blueshift from 315 to 305 nm was observed, attributed
to the photoinduced electron transfer from the electron-rich trispyrazoles to electron-poor PA47.
This assignment was also confirmed by computational MO analysis (vide infra).

Figure 3.5. Emission spectra of 3.1 & 3.2 (15µM) in THF/H2O (20:80) upon addition of PA from
0 to 30µM.
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The fluorescence quenching was analyzed using the Stern– Volmer (S-V) relationship48, I0/I = 1 +
KSV[PA], where, I 0 and I are the fluorescence intensities of nanoaggregates before and after the
addition of PA, and KSV is the Stern-Volmer constant. A S-V plot for 3.1 – 3.3 (Figs. 3.6, A3.23
& A3.24) contain a linear (Io/I) vs. [PA] section at low PA concentration, corresponding to Ksv
values of 9.3 × 104 M-1, 1.1 × 105 M-1 and 4.6 × 104 M-1 for 3.1, 3.2 and 3.3, respectively. The
higher Ksv value of compound 3.2 is in line with literature values reported for the detection of PA
by Stern-Volmer equation49 At higher concentrations of PA, the graph shows an upward
curvature, due to the super-amplified quenching eﬀ ect50. The AIEE-turned on fluorescence was
turned off by the addition of PA, so that the luminescent blue color disappeared after the addition
of 3 x 10-6 mol PA (Figure A3.25).

Figure 3.6. (a) Stern-Volmer plot for the complex 3.2 with PA (b) SV plot obtained at lower
concentration of PA.
3.4.2. 1H NMR studies of PA-trispyrazole complexes
1

H NMR spectra were recorded for compounds 3.1 and 3.2 upon stepwise addition of PA to

confirm the complexation of PA. (Figs. 3.7 & A3.26). Addition of PA to 3.1 and 3.2 resulted in
significant shifts in the resonances of both the host (trispyrazole) and the guest (picric acid)
protons. Especially the one corresponding to the -OH (11.97 ppm in free PA vs. 7.30 ppm in 3.1PA), and-CH of PA (9.20 in free PA to 9.13 ppm in 3.1-PA), shifts are consistent with
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complexation. The corresponding shifts for - OH and -CH protons for 3.2-PA are 11.97 ppm to
8.07 ppm and 9.20 ppm to 9.04 ppm, respectively. A complete list of 1H-NMR chemical shifts of
3.1, 3.2, 3.3 and their PA complexes is in Table A3.2. The 1H NMR of mixtures of 3.4 and 3.5
with various concentrations of PA do not show shifts in resonances, suggesting that no
tripyrazolyl-PA interactions are present.

Figure 3.7. Partial 1H-NMR spectra of 3.1 and 3.1-PA. (1 in the figure corresponds to 3.1)
3.4.3. Single crystal X-ray diffraction studies of PA-trispyrazole complexes
Three single-crystal X-ray structures were obtained for PA-trispyrazole compounds as follows:
1:1 (3.1-(PA), (Fig. 3.8) and 1:3.5 (3.1-(PA)3.5, (Fig. 3.8b), complexes with compound 3.1:PA
and a 1:2 complex with compound 3.3:PA (3.3-(PA)2). Single crystals were grown from acetone
solutions of PA and 3.1 (or 3.3) in 1:1 and 3:1 ratio. The structures are stabilized by strong Hbonding between pyrazole N-atoms and phenolic proton from PA, and π-π interaction between
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the ligand and picric acid. The crystals obtained were thin needles, and hence the diffraction
quality was poor. However, the data quality was sufficient to reveal important structural features
that enable complexation. The host-guest complex 3.1(PA) crystallizes in the monoclinic C2/c
space group with the whole complex in the asymmetric unit. The conformation of the ligand is
not retained in the complex, with all three pyrazolyl groups on one side of the phenyl plane. The
crystal structure is also characterized by numerous π-π interactions between the phenyl rings of
the host. When the crystals were grown from an acetone solution containing 1:3 ratio of 3.1 to
PA, the complex obtained was 3.1(PA)3.5, where three PA molecules are bound to the three
pyrazolyl N-atoms and the fourth is wedged between the phenyl rings of the pyrazole and is
stabilized purely by π-π interactions (centroid-centroid distance between the PA ring and one of
the phenyl groups is 3.657 Å on either side). The crystal is in monoclinic P2/c space group with
the whole ligand and 3.5 molecules of the PA present in the asymmetric unit. The three H-bonded
N…O distances between pyrazolyl N-atoms and respective phenolic oxygen are 2.614(6) Å,
2.542(6) Å and 2.601(6) Å. Host-guest complex 3(PA)2 crystallizes in monoclinic P21/m space
group with one half of the complex in the asymmetric unit. All three 4-(3-chloro-phenyl)pyrazolyl groups are arranged on one side of the triethyl benzene ring. One of the two PA
molecules is stabilized by a H-bond with a pyrazolyl N-atom (N…O distance: 2.568(5) Å),
whereas the other PA is stabilized by intermolecular π-π interactions (centroid-centroid distance:
3.686 Å; Fig. 3.9 shows the crystal packing diagram depicting the π-π interactions). Comparison
of the three crystal structures makes evident that both H-bonding and π-π interactions are crucial
for the stabilization of PA guest molecules by tris-pyrazole compounds.
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Figure 3.8. Crystal structures of [3.1](PA) (top) and [3.1](PA)3.5. H-atoms omitted for clarity

Figure 3.9. Crystal packing diagram of 3.3(PA)2 viewed parallel to a-axis. H-atoms are omitted
for clarity
Furthermore, to investigate the sensing preference of 3.1 and 3.2 aggregates for PA over various
nitro compounds, fluorescence titrations with PA, nitromethane (NM), nitrobenzene (NB), 2nitrophenol (2-NP), 4-nitrophenol (4-NP), and other aromatic compounds, such as benzoic acid
(BA) and benzoquinone (BQ). The quenching eﬃciencies of PA towards 3.1 and 3.2 were found
to be 92% and 91%, respectively, significantly higher than other compounds (Fig. 3.10).
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Figure 3.10. Fluorescence quenching efficiency of complexes 3.1 and 3.2 with various nitro
aromatic compounds.
For the detection of PA vapors, a Whatman™ filter paper strip impregnated with 3.1 or 3.2 (10
mM in THF) and was exposed to the PA vapors (Fig. 3.11).

Figure 3.11. Change in emission spectra of 3.1 & 3.2 (1 × 10-4 M) on exposing to the vapors of
PA with different time intervals. (Δt = 2 mins) (λex= 255 nm).
Monitoring the exposure over a period of 30 min, showed that the fluorescence intensity was
quenched by ~ 60% and 70% for 3.1 and 3.2, respectively. A separate chart of comparison of the
fluorescence response times of test strips with PA vapors is also presented in Fig. 3.12. After
irradiation with a UV lamp, the spots begin to darken after 20 min of strip exposure to PA vapors
(Fig. A3.27). These results show the practical applicability of derivatives 3.1 and 3.2 towards the
instant visualization of traces of PA. Therefore, these compounds are suitable probes for PA in
the vapor phase and their efficiency is comparable to other systems reported in the literature51.
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Figure 3.12. Comparison plot of ﬂuorescence quenching performance for compounds 3.1 and 3.2
with PA vapors upon different exposure of time (0 to 30 min).
Compound 3.2 was also used to detect the PA in contact mode by applying small spots (10 µL) of
various concentrations of PA solution into compound 3.2 impregnated test strips. The dark color
spot was observed not only at higher concentrations (1 mM) of PA, but also in nanomolar
concentrations (Fig. 3.13).

Figure 3.13. Photographs of compound 3.2 impregnated test strips under various concentrations
of PA under illumination of 365 nm UV lamp blank, 1 × 10-3M, 1 × 10-4M, 1 × 10-6M and, 1 × 109
M respectively (left to right)
These observations confirm that the test strips containing trispyrazole compounds are responsive
to even very low concentrations PA52. In addition, a gloved thumbprint of PA when rubbed on
compound 3.2 was visualized under illumination by a 365 nm UV lamp (Fig. 3.14). Therefore,
paper strips prepared by dip coating a solution of these compounds provide a simple, portable,
sensitive, selective and low-cost method for the detection of PA, which could lead to real time
applications such as onsite detection, forensic research, etc.
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Figure 3.14. Pictures of compound 3.2 impregnated test strips under diﬀerent experimental
conditions under illumination of 365 nm UV lamp (i) PA under daylight. (ii) PA under UV light.
(iii) After removal of the PA (iv) and (v) Thumb impressions before and after rubbing with PA.
3.4.4. Computational study
Geometry optimization of the complexes of trispyrazole 3.1 with one, two and three molecules of
PA have been performed using a density functional ωB97XD method developed by HeadGordon’s group39, which includes a correction for dispersion, with the 6-31G* basis set. The
optimized geometries show a clear pattern of H-bond formation between the OH hydrogen and
one of the N atoms of a pyrazole ring in 3.1-PA, 3.1-(PA)2 and 3.1-(PA)3, with the H-N distance
varying in the 1.682-1.916 Å range. Interestingly, in 3.1-(PA)3, one PA molecule is linked with a
pyrazole ring via H-bonding, but the second PA molecule is trapped via π-stacking interaction.
Even after repeated attempts to force a second H-bonding interaction by changing the initial
geometry, the optimization still converged to the same structure with π-stacking interaction The
TD-DFT calculations carried out at the ωB97XD/6-311G** level of theory have shown the
existence of excited electronic states, which have much higher oscillator strengths than the other
states. For instance, for 3.1-PA, the excitation energy for the 9th state was calculated to be 255.8
nm, with the oscillator strength of 0.167 being at least one order of magnitude higher than those
for the lower lying states and for consequent higher lying states up to 230 nm. For 3.1-(PA)2, a
similar bright state is found at 256.1 nm, with the oscillator strength of 0.173. For 3.1-(PA)3, two
bright states have been found in the same wavelength range, at 258.3 nm (f = 0.178) and 254.4
nm (f = 0.155). Figure 15 illustrates molecular orbitals (MOs) involved in the transition to the
bright state in 3.1-PA. Clearly, the unoccupied MOs, accepting an electron, are localized on PA,
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whereas the occupied MOs, from which an electron is removed during the transition, have a
significant contribution from the pyrazole ring forming a hydrogen bond with the picric acid.
Thus, the calculations confirm the hypothesis that the bright absorption/emission observed
experimentally is due to a charge transfer state, with an electron being excited from pyrazole to
picric acid.

Figure 3.15. Occupied and vacant MOs involved in the bright transition in the complex of
trispyrazole with one picric acid molecule.
3.5. Conclusions
In summary, we have designed and prepared five tripodal pyrazole compounds and studied their
AIEE characteristics owing to their intramolecular rotation of phenyl rings, which were blocked
by increasing the ratio of water in THF solution. These nanoaggregates serve as sensitive sensors
for picric acid as confirmed by absorption, emission and NMR spectral techniques and
corroborated by single-crystal X-ray crystallography and DFT calculations. These compounds
show a good quenching constant with a low detection limit. In addition, test strips made of filter
paper impregnated with these compounds detect PA vapors efficiently leading to practical field
applications. Compounds 3.1 – 3.3 are selective and sensitive detectors towards picric acid in the
vapor phase, a challenging task, due to its much lower vapor pressure compared to other nitro
explosives. Compounds 3.1 and 3.3 have detection limits of 458 and 325 ppb for PA, comparable
to the sensors reported by Roy et al47. As these chemosensors are characterized by sensitivity, fast
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response, simplicity, portability, and a low-cost, they can play kernel role in real time detection of
explosives, opening new vistas for the development of simple, new fluorescent AIEE probes.
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CHAPTER 4
Chemistry of mercury(II)-pyrazolyl complexes; characterization and extraction studies

4.1. Abstract
This project is designed to focus on the removal of both organic and inorganic mercury from lowlevel nuclear waste (LLW) present in the Savannah River nuclear waste site (SRS). We have
designed several pyrazole-based ligands, including tripodal trispyrazoles. Pyrazoles are versatile
soft-donor ligands with a high affinity for mercury(II). Herein we describe seven new compounds
incorporating differently substituted pyrazoles, namely, [Hg(CH2COCH3)(4-NO2-bis(2,4dinitrophenyl)pz)] [4.1], (Et3NH)[Hg2Cl2(-3,5-Me2-4-NO2-pz)3] [4.2], [Hg2(CH3COO)Cl2(3NO2-pz)] [4.3] , [HgCl(-4-NO2-3,5-Me2-pz)]n [4.4], [Hg(-Cl)Cl(4-I-pzH)]n [4.5], [Hg(-Cl)2(4I-pzH)2]n [4.6]

and

[HgCl(2,4,6-Et3-1,3,5-tris(4Ph-pz)]n [4.7].

These

complexes

were

characterized by single crystal X-ray diffraction, 1H NMR and IR spectroscopic techniques and
elemental analyses, showing a variety of nuclearities and coordination numbers. Preliminary
results of the selective extraction of Hg(II) from Ln(III)-containing solutions are also reported.

4.2. Introduction
The Savannah River low nuclear waste site contains about 60 metric tons of mercury, which was
used as a catalyst to dissolve the aluminum cladding of reactor fuel (canyon processing). Even
though mercury is present in various forms, i.e. Hg(0, I, II), organomercury (methylmercury(II))
is its most abundant.1 Existing methods for the removal of mercury from this site is not effective
enough, and several chemists/engineers are working on it to overcome the challenges.2
Pyrazoles can be good candidates to extract mercury from both acidic and alkaline waste. The
tunability of the pyrazoles is one of the good reasons for its use. Physical and chemical properties,
such as acidity/basicity, steric and electronic environment, and solubility can be tuned easily by
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varying the substituents on the 3-, 4- and 5-positions of the ring.2 3 4 Pyrazoles can also be easily
incorporated in monopodal to the polypodal molecular platforms. Lipophilic ligands are desired
to extract mercury from the aqueous radioactive waste.5 Extraction of mercury, lead, and other
toxic metals from the environment is another challenging issue, since they exist in water soluble
salt form. Among the available methodologies, the use of lipophilic ligands to extract the toxic
metals out of aqueous solution can be an effective way for their removal from the environment.6
Besides the nuclear waste, it is found everywhere in the Earth's lithosphere. From the lithosphere,
it is emitted in the atmosphere as elemental gaseous Hg0 form.7 From the atmosphere, it goes
back to water and soil and gets buried in terrestrial reservoirs (lithosphere) and the cycle
continues. While approximately 500 mg/year are emitted back naturally, human activities, such as
mining, fossil fuel combustion, and industrial production, have augmented the emission of
mercury from lithosphere to atmosphere 2000 mg/year.8
Regardless of the source and form of mercury, its extraction and removal have gained
considerable research interest, because of its toxicity to human as well as other living creatures
and its wide distribution.9 Mercury is toxic in its all forms and exposure to them can be
detrimental to the kidney, brains, and lungs, resulting in hepatotoxicity, neurotoxicity,
nephrotoxicity, or pulmonary toxicity.10 Thiol compounds, such as dimercaptopropanesulfonic
acid (DMPS), dimercaptosuccinic acid (DMPA), are being used currently in clinical chelation
therapy of mercury poisoning.11 However, they are not well optimized, nor effective enough.12
Also, catabolism of Cys in the gastrointestinal tract and blood plasma limits their use in chelation
therapy.13 N-acetylcysteine (NAC) is another ligand used in chelation therapy; it has been found
that post-exposure treatment with NAC has increased the concentration of mercury in the brain,
because mercury-NAC complex acts as a structural and functional homolog of cysteine and is
transported to the brain.14 Moreover, although S-donor ligands have a higher binding constant
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with Hg(II), they may also replace the Cl atom present in most of the organic and inorganic
compounds of mercury, leaving the concentration of chloride. Therefore, it is useful to study
other options for the therapeutic chelation of mercury. Pyrazoles may be suitable ligands to
overcome the limitation, because they have been used in vivo for other treatments and proved to
be biologically compatible.15 Also, as a result of the structural flexibility of the mercury, pyrazole
N-atoms selectively bind Hg-compounds without replacing Cl- ions.16
The “soft acid” nature of the Hg(II) acceptor ion favors strong binding to “soft base” donor
atoms, such as nitrogen, sulfur, selenium, and phosphorus.17 Hg(II) has d10 electronic
configuration and it prefers the formation of low-coordinate linear, trigonal planar, or tetrahedral
complexes.16 Tripodal ligands are better over the monopodal ligands, because the chelate effect.13
Pyrazoles and benzimidazole having heterocyclic recognition sites have been reported to be more
effective than acyclic ones.18
The primary objective of our study is to explore the pyrazole/pyrazolate chemistry and use the
ligands as mercury getters to extract mercury from Savannah River nuclear waste. Herein, we
report the synthesis and structural characterization of seven new mercury pyrazole/pyrazolate
complexes varying from mononuclear to polynuclear and linear to octahedral coordination,
namely, [PNDP-pzHgCH2COCH3] [4.1] (a mononuclear, linear coordination compound),
[(Hg2Cl2(-3,5-Me2-4-NO2pz)3) (Et3NH)] [4.2] (a dinuclear capped, tetrahedral coordination
compound with completely novel motif), [Hg2(CH3COO)Cl2(3-NO2-pz)] [4.3] (a pentanuclear,
linear and trigonal planar coordination compound), [Hg(-Cl)(-3,5-Me2-4-NO2pz)]n [4.4] (a
polymeric, tetrahedral coordination compound), [HgCl(-Cl)(4-I-pzH)]n [4.5] (a polymeric,
tetrahedral coordination compound), [Hg(-Cl)2(4-I-pzH)2]n [4.6] (a polymeric, octahedral
coordination compound), and [HgCl(2,4,6-Et3-1,3,5-tris(4Ph-pz)]n [4.7] (a polymeric, tetrahedral
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coordination compound). Selective extraction of Hg2+ from an aqueous solution of Hg2+and Ln3+
was carried out in organic media and was found promising.

4.3. Experimental
4.3.1. Materials and methods
Reagent grade chemicals were purchased from Aldrich Chemical Co, Alfa Aesar, Fisher scientific
or ACROS Organics. Further purification was carried out for solvents for Shlenk line syntheses.
1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene was synthesized using the literature.9 A new
tripodal ligand; T(4Ph)pzH was synthesized by slight modification of the literature.19 PNDPpzH20
and 3,5 dimethyl 4nitropyrazole21 were synthesized by using the literature methods. X-ray
structures were obtained from ‘Bruker D8 CMOS’ diffractometer. 1H-NMR spectra were
recorded on a 400 MHz BrukerAvance spectrometer and were referenced using the residual
solvent proton resonances. FT-IR spectra were recorded with an ATR-IR, diamond Spectrometer.
Elemental analyses were recorded from GALBRAITH Laboratories. Inc., Knoxville, TN, USA.
4.3.1.1. Synthesis of [PNDP-pzHgCH2COCH3] [4.1]
50.3 mg (0.1 mmol) PNDPpzH was added to the suspension 31.8 mg (0.1 mmol) of
Hg(CH3COO)2 in 6 mL acetone and stirred for 4 days. The compound was crushed out adding 20
mL of water and the byproduct (CH3COOH) in the solution was filtered off. The precipitate was
washed with water followed by diethyl ether. The solid was dried under vacuum. Molecular
weight: 701.9 g/mol. Yield, 50 mg (71%). Light yellow colored crystals of X-ray quality were
obtained by the slow evaporation of the compound solution in acetone. Anal. Calcd: C, 30.80; H,
1.58; N, 13.97. Found C, 30.08; H, 1.17; N, 14.84. IR (ʋmax, cm-1): 3095(w), 1600(w), 1531(s),
1344(s), 1211(w), 1068(w), 914(m), 833(s), 738(m) 1H NMR (acetone-D6, 298K,  in ppm,
400MHz): 1.20(s) (3H, -CH3), 2.14(s) (1H, -CH2), 2.61(s) (1H, -CH2), 8.20(d) (2H, -CH/pz),
8.76(d) (1H, -CH/pz), 8.79(d) (1H, -CH/pz), 9.04(d) (2H, -CH/pz).
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4.3.1.2. Synthesis of (Et3NH)[(Hg2Cl2(-3,5-Me2-4-NO2pz)3)] [4.2]
27.1 mg (0.1 mmol) HgCl2 and 21.1 mg (0.15 mmol) 3,5-(CH3)2-4-NO2-pzH in 8 mL CH2Cl2 or
acetone was stirred for 20 minutes. Addition of 20.85 L (0.15 mmol) Et3N to the suspension
resulted clear solution. Colorless crystals of X-ray quality were obtained by slow evaporation of
the solution. Molecular weight: 994.65 g/mol. Yield, 37 mg (74%). Anal. Calcd: C, 25.36; H,
3.45; N, 14.08. Found C, 24.70; H, 3.12; N, 14.29. IR (ʋmax, cm-1): 3202(w), 3129(w), 2885(w),
1587(w), 1544(m), 1465(w), 1411(w), 1355(s), 1172(s), 1029(w), 991(w), 831(s), 767(m). 1H
NMR (CDCl3, 298K,  in ppm, 400MHz): 1.42(t) (9H, -CH3/Et3NH), 2.61(s) (18H, -CH3/pz),
3.27(q) (6H, -CH2/Et3NH).
4.3.1.3. Synthesis of [Hg2(CH3COO)Cl2(3-NO2-pz)] [4.3]
27.1 mg (0.1 mmol) HgCl2, 31.8 mg (0.1 mmol) Hg(CH3COO)2, 11.3 mg (0.1 mmol) 3-NO2-pzH
and 13.9 L (0.1 mmol) Et3N in 8 mL MeOH was stirred for 24 h. The resulting precipitate was
dried under vacuum. Colorless crystals of X-ray quality were obtained by slow evaporation of the
acetone solution of the precipitate.
4.3.1.4. Synthesis of [Hg(-Cl)(-3,5-Me2-4-NO2pz)]n [4.4]
27.1 mg (0.1 mmol) HgCl2 and 14.1 mg (0.1 mmol) 3,5(CH3)24NO2pzH in 8 mL MeOH was
stirred for 20 minutes. Addition of 13.9 L (0.1 mmol) Et3N to the suspension resulted clear
solution. Colorless crystals of X-ray quality were obtained by the slow evaporation of the
solution. Molecular weight: 752.32 g/mol (for a monomeric unit). Yield, 67 mg (89%). Anal.
Calcd: C, 15.97; H, 1.61; N, 11.17. Found C, 16.87; H, 1.85; N, 11.01. IR (ʋmax, cm-1): 2923(w),
1546(s), 1475(s), 1413(s), 1380(s), 1357(s), 1174(s), 995(m), 883(s), 763(m). 1H NMR (DMSOD6, 298K,  in ppm, 400MHz): 2.54(s) (CH3/pz).
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4.3.1.5. Synthesis of [HgCl(-Cl)(4-I-pzH)]n [4.5]
Mixture of 27.1 mg (0.1 mmol) HgCl2, 19.4 mg (0.1 mmol) 4-I-pzH, and 13.9 L (0.1 mmol)
Et3N were stirred in 8 mL for 24 h. The suspension was filtered. Colorless crystals of X-ray
quality were obtained by slow evaporation of the filtrate. Molecular weight: 465.54 g/mol (for a
monomeric unit). Yield, 29 mg (62%). Addition of excess Et3N did not deprotonate the pyrazole.
Similar procedure without using the Et3N also gave the same result. IR (ʋmax, cm-1): 3228(w),
1627(m), 1452(m), 1369(s), 1311(s), 1207(m), 1162(w), 1062(s), 948(m), 836(s), 671(m). 1H
NMR (THF-D8, 298K,  in ppm, 400MHz): 7.57(s) (-CH/pz), 10.83(-NH/pz). (CDCl3, 298K, in
ppm, 400MHz): 7.65(s) (-CH/pz).
4.3.1.6. Synthesis of [Hg(-Cl)2(4-I-pzH)2]n [4.6]
Mixture of 27.1 mg (0.1 mmol) HgCl2, 38.8 mg (0.2 mmol) 4-I-pzH and 27.8 L (0.2 mmol)
Et3N were stirred in 8 mL for 24 h. The suspension was filtered. Colorless crystals of X-ray
quality were obtained by the slow evaporation of the filtrate. Molecular weight: 659.44 g/mol (for
a monomeric unit). Yield, 44mg (67%). Addition of excess Et3N did not deprotonate the pyrazole.
Similar procedure without using the Et3N also gave the same result. IR (ʋmax, cm-1): 3214(w),
3085(s), 1710(w), 1461(s), 1373(s), 1193(m), 1132(s), 1062(s), 939(s), 856(s), 690(s). 1H NMR
(CDCl3, 298K,  in ppm, 400MHz): 7.67(s) (-CH/pz).
4.3.1.7. Synthesis of [HgCl(2,4,6-Et3-1,3,5-tris(4Ph-pz)]n
27.1 mg (0.1 mmol) HgCl2 and 63 mg (0.1 mmol) [2,4,6-Et3-1,3,5-tris(4Ph-pz)] were stirred in
acetone for 24 h. Colorless crystals of X-ray quality were obtained by slow evaporation of the
solution. Molecular weight: 902.33 g/mol (for a monomeric unit). Yield, 75 mg (83%). Anal.
Calcd: C, 56.61; H, 5.34; N, 9.25. Found C, 56.73; H, 5.03; N, 9.12. IR (ʋmax, cm-1): 3104(w),
2960(w), 1706(w), 1671(w), 1604(w), 1562(w), 1446(w), 1363(w), 1361(w), 1280(w), 1220(w),
1176(s), 1068(w), 1008(w), 952(m), 867(w), 755(s), 692(s), 655(w). 1H NMR (CD2Cl2, 298K, 
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in ppm, 400MHz): 1.03(t) (9H, -CH3, Et/Tpz), 2.12(s) (6H, -CH3/acetone), 2.82(q) (6H, -CH2,
Et/Tpz), 5.51(s) (6H, -CH2, Tpz), 7.18-7.38(m) (18H, -Ph +pz(C5), 7.81(s) (3H, pz(C3))
4.3.2. Extraction study
Solvent extraction experiment was carried out to study the selective extraction of mercury from
the mixture of mercury (Hg2+) and lanthanide salts (Ln3+) in aqueous solution using two ligands
(ligands of complexes 4.4 and 4.7). Employing 3,5-(CH3)2-4-NO2pzH; ErCl3 + Sm(NO3)3 +
HgCl2 (in an equimolar amount) was dissolved in a vial and 3,5-(CH3)2-4-NO2pzH (extractant)
and Et3N in an equimolar amount with that of each salt was dissolved in CHCl3. Both solutions
were kept in a separatory funnel and shaken for a few minutes. Slow evaporation of the organic
layer gave 4.4, confirming that this ligand selectively extracts Hg out of aqueous solution.
Employing T(4Ph)pz; Sm(NO3)3 + HgCl2 (equimolar amounts) were dissolved in a vial and
T(4Ph)pz (extractant) in an equimolar amount with that of each salt was dissolved in CHCl3. Both
solutions were kept into a separatory funnel and shaken for a few minutes. Slow evaporation of
the organic layer gave 4.7, confirming that this ligand selectively extracts Hg out of aqueous
solution. Several reactions with many lanthanide salts and using various solvents were carried out
with all the pyrazoles employed in this work and several spectroscopic techniques were employed
to see if the ligand binds lanthanides but, the result was always negative.
4.4. Results and discussions
4.4.1. Synthesis and crystal structures of complexes
Water-soluble mercury salts, either HgCl2 or Hg(CH3COO)2 or both, were used to synthesize the
compounds.

Five

different

types

of

pyrazolyl

ligands

with

a

wide

range

of

chemical/electronic/steric properties were used. Six out of seven pyrazoles used are monopodal
1H pyrazoles and the last one is a tripodal pyrazole. Compounds 4.4-4.7 are polynuclear. All the
compounds are organosoluble (soluble in CH2Cl2, CHCl3, and acetone) and none of them are
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water soluble. Compound 4.4, however, is barely soluble in any organic solvents other than
DMSO, although crystals were grown from MeOH or CH2Cl2. 1H-NMR of in situ reaction
corresponds to dimeric form and the peaks are highly shifted from the pyrazole, confirming that it
polymerizes via dimerization. 1H NMR of the compounds are shown in Figures 4.8, 4.9 and A4.1A4.5. Compounds 4.1 and 4.3 have a long range of intermolecular (H-bonding) interaction
forming a supramolecular structure. All compounds except 4.2 are neutral whereas, 4.2 has
Et3NH+ counter cation. Regardless of the stoichiometry, compound 4.5 and 4.6 always cocrystallize but, stoichiometry determines the major and minor products. Addition of excess base
in 4.5 and 4.6 does not deprotonate the pyrazole, hence the compounds are stable over a wide pH
range (acidic to alkaline).
Although Hg prefers low coordination numbers (usually 2 and 3), we synthesized seven
compounds ranging from linear to octahedral (2-6) coordination numbers. [4.1] is a mononuclear
Hg compound with linear coordination geometry around Hg(II). [4.2] is a dinuclear triclipped
compound with each Hg(II) center coordinated with one N-donor atom from each pyrazole and
one terminal chlorine, giving tetrahedral geometry. This is an unprecedented motif for Hg
compounds. A pentanuclear Hg compound [4.3], has two Hg atoms in T-shaped coordination
geometry and the remaining three Hg atoms are in linear coordination geometry. The polymeric
compounds [4.4], [4.5] and [4.7] compounds have tetrahedral geometry on Hg center, whereas
[4.6] has octahedral geometry. X-ray structures of 4.1-4.7 are given in Figures 4.1-4.7
respectively. The crystallographic details are given in the appendices Tables A4.1 and A4.2.
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Figure 4.1. The molecular structure of 4.1 (top), long-range Hg…O interaction forming
supramolecular structure (bottom); H-atoms are omitted for clarity. Color code: Yellow, Hg;
black, C; blue, N; red, O.

Figure 4.2. The molecular structure of 4.2, showing tetrahedral geometry around Hg center; Hatoms are omitted for clarity. Color code: Yellow, Hg; black, C; blue, N; red, O; green, Cl.
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Figure 4.3. The molecular structure of 4.3; H-atoms are omitted for clarity. Color code: Yellow,
Hg; black, C; blue, N; red, O; green, Cl.

Figure 4.4. The molecular structure of 4.4 (right) and monomeric unit (left); H-atoms are omitted
for clarity. Color code: Yellow, Hg; black, C; blue, N; red, O; green, Cl.

Figure 4.5. The molecular structure of 4.5 showing tetrahedral geometry around Hg-center; Hatoms [other than pz (N-H)] are omitted for clarity. Color code: Yellow, Hg; black, C; blue, N;
red, O; green, Cl; violet, I.

84

Figure 4.6. The molecular structure of 4.6 showing octahedral geometry around Hg-center; Hatoms [other than pz (N-H)] are omitted for clarity. Color code: Yellow, Hg; black, C; blue, N;
red, O; green, Cl; violet, I.

Figure 4.7. The molecular structure of 4.7 showing tetrahedral geometry around Hg-center.; Hatoms are omitted for clarity. Color code: Yellow, Hg; black, C; blue, N; red, O; green, Cl.

Figure 4.8. 1H NMR of dinuclear unit of 4.4. in MeOD.
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Figure 4.9. 1H NMR of 4.4. in DMSO-d6.
4.4.2. Extraction study
As described before (in 4.3.2), two ligands; 3,5-(CH3)2-4-NO2pzH and T(4Ph)pz successfully
extracted HgCl2 in organic media (CHCl3) from the aqueous mixture of lanthanide salts. N-donor
ligands are considered promising ligands for binding mercury.22
4.5. Conclusion
Seven new Hg(II) complexes with unprecedented motifs and diverse nuclearities -- ranging from
mononuclear to polynuclear -- and diverse geometry -- ranging from linear to octahedral -- were
synthesized and characterized with SCXRD, NMR, IR, and elemental analyses. Two of the
ligands were used to extracting Hg from an aqueous mixture of Hg2+ and Ln3+.
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CHAPTER 5
Synthesis and characterization of palladium pyrazolates and their use as a catalyst
5.1. Abstract
Nine new Pd-pyrazolyl complexes [PdCl2(4-(CH2)3-pzH)2] [5.1], [(Et3NH)2Pd2Cl4(-3-NO2-pz)2]
[5.2], [(Et3NH)2Pd2Cl4(-3,5-(CH3)2-4-NO2-pz)2] [5.3], [(Et3NH)2Pd2Cl4(-4-NO2-pz)2] [5.4],
[(Et3NH)2Pd2Cl4(-4-(CH2)2OH-pz)2] [5.5], [(Et3NH)2Pd3Cl4(-3,5-(CH3)2-4-NO2-pz)4] [5.6],
[(Et3NH)2Pd3Cl4(-4-NO2-pz)4]

[5.7],

[(Et3NH)2Pd3Cl4(-4-OH-pz)4]

[5.8]

and

[(Et3NH)1.5Pd3Cl3(μ3-OH0.5)(-4-NO2-pz)3]2 [5.9] were synthesized and characterized by single
crystal X-ray crystallography, 1H-NMR, IR and elemental analyses (C, H, N). 5.1, 5.5, and 5.8
are water-soluble complexes. Compound 5.1 is mononuclear, compounds 5.2, 5.3, 5.4 and 5.5 are
dinuclear, compounds 5.6, 5.7 and 5.8 are linear trinuclear and 5.9 is hexanuclear (dimer of cyclic
trimers). The latter is an unprecedented motif in palladium coordination chemistry. 5.2 and 5.3
were studied as catalysts for Sonogashira coupling reactions and found promising, opening up
catalytic prospects for Pd-pyrazolates. A range of seven arylated alkynes (4a – 4h) were
synthesized from terminal alkynes and corresponding aryl halides through Sonogashira crosscoupling reactions of C(aryl)-C bond formation using the palladium pyrazolate dimer catalysts
5.2 or 5.3. Compounds 4b and 4e are same, but prepared from different starting materials. All
reactions were carried in open air, in the absence of Cu(I) co-catalyst, and under mild conditions.
Reaction conditions were optimized for a reaction and the optimized conditions were used for the
other reactions. The metathetical ligand reactivity of 5.9 was probed with silver cyanide and IR
confirmed the substitution of terminal chlorides by cyanides.
5.2. Introduction
Despite several demerits associated with phosphines, such as toxicity, instability (ligands are
added separately to produce Pd-catalyst in situ because of stability problem) and air and moisture
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sensitivity,1 phosphine based Pd-compounds are the most used catalysts for the C-C crosscoupling reactions. In addition, phosphines are toxic and also produce unwanted toxic side
products.1 The aforementioned reasons make them difficult in handling.2 Due to lack of
development of more convenient ligands, Pd catalysis system with the externally added ligands,
mostly phosphines, is the most popular catalytic system for the reactions to date.3 NHC ligands
are being investigated as an alternative of phosphine ligands but, they are handicapped by the lack
of coordinative flexibility.2a
Many of the reported Sonogashira coupling reactions use Cu+ as a co-catalyst, which has the
serious disadvantage of forming homocoupled products of terminal alkynes (Glasser-Hay
coupling).4 Separation of cleaner products is always a challenge for the Cu+-cocatalyzed
reactions.4-5 Moreover, Cu+ inhibits the activation of Pd-catalysts and promotes oxidation of Pd(0)
to Pd(I) promoting alkyne polymerization, which again reduces the yield of products and makes
purification difficult.6 Besides the disadvantages associated with using Cu as a cocatalyst, it is the
most prevalent way for Sonogashira reactions in industries and academia.5a, 7
The commonly used solvents in the Sonogashira reactions are DMF2a, 8, NMP8b and toluene.9
Separation of the products is difficult from the DMF, which requires additional work up. A
greener and safer solvent is always desirable.
Although investigations are rapidly advancing in the field, choosing a right solvent, ligand, base,
optimization of temperature and whether to use (or not to use) Cu as a cocatalyst have become a
big challenge.7b Comparing to Suzuki and Heck coupling, limited studies have been carried out
on Sonogashira coupling and optimization studies have become cutting edge research.7b
Use of bulky ligands is always desired to favor oxidative addition and reductive elimination
steps.10 To our best knowledge, no palladium(II) pyrazolate dimer as a catalyst for Sonogashira
coupling reactions has been reported yet. Although many natural multinuclear catalysts are
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known, synthetic catalysts are dominated by monomers, because of the limited understanding of
underlying synergism and reactivity of multimetallic assemblies.11
A weaker -donor, stronger -acceptor, and more labile N-donor pyrazole ligands are expected to
have higher catalytic benefits and N-N donor ligands favor the oxidative addition over P-P donor
ligands.12 The catalytic advantages of N-donor ligated Pd-compounds over non-ligated Pd-salts
and phosphine based ligands have been investigated.13 They also proved the catalytic superiority
of the dimers compared to monomers, and among the dimers, the one with shorter Pd---Pd
distance was found superior over other dimers. Pd complexes with N-based ligands have proven
to be versatile and efficient for catalyzing a broad range of cross-coupling reactions under aerobic
conditions.2a
Chemical nature of alkyl/aryl halide (R-X) is crucial for the Sonogashira catalysis. Electron
withdrawing groups reduce the electron density of C-X bond, weakening the bond and making a
reaction easier.14 Although PdCl2 and Pd(OAc)2 have been tested for some of the Sonogashira
coupling reactions,15 they suffer of several drawbacks, such as high amount of catalyst is
required,14b, 15 a longer reaction time is required.16
In this work, we synthesized nine new palladium pyrazolate compounds including three water
soluble ones. Compounds 5.2 and 5.3 have been employed as a catalyst for a Sonogashira
coupling reaction producing 1,2-diphenylacetylene and rest of the cross coupled compounds were
synthesized using 5.3. Seven compounds (eight different reactions) were synthesized for the study
and the synthesized compounds are shown in Scheme 5.1. They have excellent and catalytic
activity with a slight superiority of 5.3 over 5.2 for the optimization reaction. Terminal Cl- the
substitution of 5.9 with CN- was initially accessed by color change and further confirmed by FTIR spectroscopy.
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Scheme 5.1. Sonogashira cross-coupling compounds synthesized in this study.
5.3. Experimental
5.3.1. Materials and Methods
Reagent grade chemicals were purchased from Aldrich Chemical Co, Alfa Aesar, Fisher scientific
or ACROS Organics and used as received. THF was distilled over Na/benzophenone, CH2Cl2 was
distilled over CaCl2/CaH2 and MeCN was distilled over CaH2 before use. Literature procedure
was followed for the synthesis of 4-nitro-pyrazole.17 1H-NMR and

13

C-NMR spectra were

recorded on a 400 MHz or 500 MHz Bruker Avance spectrometer and were referenced using the
residual solvent proton resonance. FT-IR spectra were recorded with a Perkin Elmer Spectrum
100 FT-IR Spectrometer. The crystal structure was determined with a Bruker single crystal X-ray
diffractometer. Elemental analysis (CHN) was performed using an Elemental VarionEL CHN
elemental analyzer in Galbraith Lab. Sonogashira coupling reactions were monitored with
analytical thin layer chromatography (EMD Millipore™ Silica Gel 60 F254 Coated AluminumBacked TLC Sheets), visualized with a UV lamp. Purification of the Sonogashira products was
performed by column chromatography using Silica gel 60, 230-400 mesh.
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5.3.3.1. Synthesis of [PdCl2{4-(CH2)3-pzH)2}] [5.1]
0.1 mmol (25.9 mg) PdCl2(CH3CN)2 and 0.2 mmol (25.2 mg) 4-OH(CH2)3-pzH in 1:2 ratio was
stirred in 5 mL acetonitrile for 3 days. The reaction mixture was clear. X-ray quality single
crystals were obtained from slow evaporation of the reaction solution. (90 % yield). The
compound was characterized by SCXRD.
5.3.3.2. Synthesis of (Et3NH)2[Pd2Cl4(-3-NO2-pz)2] [5.2]
0.1 mmol (25.9 mg) PdCl2(CH3CN)2 and 0.1 mmol (11.3 mg) 3-NO2-pzH were dissolved in 5 mL
tetrahydrofuran and stirred for 20 min in room temperature. To the clear reaction solution, an
equimolar amount of trimethylamine (0.1 mmol, 13.9 mL) was added and stopped stirring
immediately while color change was observed. Golden (yellow) colored X-ray quality crystals of
5.2 were obtained by the diffusion of diethyl ether into the reaction solution. Yield: 75 mg (96
%). Anal. Calcd for C18H36N8Cl4O4Pd2 (783.18 g mol-1): C, 27.61; H, 4.63; N, 14.31. Found: C,
28.01; H, 4.73; N, 14.61. IR (ʋmax, cm-1): 3282 (s), 3143 (w), 2977 (w), 1601 (w), 2493 (w),
1531 (s) 1484 (s), 1392 (s), 1353 (s), 1216 (w), 1128 (m), 1058 (m), 1031 (w), 970 (m), 821 (s),
781 (m), 744 (s), 671 (w).

H NMR (CD3OD, 298K,  in ppm, 400MHz): 1.33(t) (18H, -
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CH3/Et3NH), 3.25(q) (12H, -CH2/Et3NH), 6.71-7.66 (4H, -CHpz) [6.71(d) (1.33H), 6.85(d)
(0.66H), 7.60(d) (1.33H), 7.66(d) (0.66H)].
5.3.3.3. Synthesis of (Et3NH)2[Pd2Cl4(-3,5-(CH3)2-4-NO2-pz)2] [5.3]
0.1 mmol (25.9 mg) PdCl2(CH3CN)2 and 0.1 mmol (14.1 mg) 3,5 Me24-NO2-pzH were dissolved
in 6 ml CH2Cl2 and stirred for 20 min in room temperature. To the clear reaction solution, an
equimolar amount of trimethylamine (0.1 mmol, 13.9 mL) was added and continued stirring for
20 minutes while color change as well of a lot of precipitate observed. Resulting reaction mixture
was stirred to 12 h until all the precipitate disappeared. Golden (yellow) colored X-ray quality
crystals of 5.3 were obtained by the diffusion of diethyl ether into the reaction solution. Yield: 79
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mg (95 %). The compound was characterized by SCXRD, 1H-NMR and elemental analysis. Anal.
Calcd. for C22H44N8Cl4O4Pd2 (839.29 g mol-1): C, 31.48; H, 5.28; N, 13.35. Found: C, 31.18; H,
5.19; N, 13.50. IR (ʋmax, cm-1): 3029 (w), 2977 (w), 2599 (w), 2495 (w), 1606 (w), 1546 (s),
1471 (s), 1409 (s), 1351 (s), 1180 (s), 1035 (w), 995 (w), 835 (s), 763 (m), 694 (w). 1H-NMR
(CD3OD, 298K,  in ppm, 400MHz): 1.45(t) (18H, - CH3/Et3NH), 3.58(q) (12H, -CH2/Et3NH),
2.76(s) (12H, -CH3pz)
5.3.3.4. Synthesis of (Et3NH)2[Pd2Cl4(-4-NO2-pz)2] [5.4]
(NH4)2PdCl4 0.1 mmol (28.4 mg) and 0.1 mmol (11.3 mg) 4-NO2-pzH was dissolved in 6 mL
methanol and stirred for 20 min. To the clear reaction solution equimolar amount of
trimethylamine (0.1mmol) was added and continued stirring for 20 min. Gold (yellow) colored
crystals of X-ray quality were grown by diffusion of diethyl ether into the reaction solution (80 %
yield). The compound was characterized by SCXRD,

1

HNMR and elemental analysis.

C18H36N8Cl4O4Pd2 (783.18 g mol-1): C. 27.61; H, 4.63; N, 4.63. Found: C, 27.91; H,4.70; N,
14.55. IR (ʋmax cm-1): 3110 (w), 3050 (w), 1498 (m), 1400 (s), 1282 (s), 1184 (w), 1041 (w), 1004
(w), 871 (w), 852 (w), 817 (m), 750 (m). 1H-NMR (CD3ODCD3, 298K,  in ppm, 400MHz): 1.48
(t) (18H, -CH3/Et3NH); 3.56 (q) (12H, -CH2/ Et3NH); 8.11 (s) (4H, -CHpz).
5.3.3.5. Synthesis of (Et3NH)2[Pd2Cl4(-4-(CH2)2OH-pz)2] [5.5]
0.1 mmol (25.9 mg) PdCl2(CH3CN)2 in 3 mL CH2Cl2 and 0.1 mmol (11.2 mg) 4-OHCH2CH2-pzH
in 4 mL MeOH was mixed together and stirred for 5 min. 2 mL MeOH was added to the reaction
solution. To the clear reaction solution equimolar amount of trimethylamine (0.1mmol) was
added and continued stirring for 20 min. Gold (yellow) colored crystals of X-ray quality were
grown by the slow evaporation of the solution (20 % yield). The compound was characterized by
SCXRD.
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5.3.3.6. Synthesis of (Et3NH)2[Pd3Cl4(-3,5-(CH3)2-4-NO2-pz)4] [5.6]
0.1 mmol (25.9 mg) (CH3CN)2PdCl2 and 0.1 mmol (14.1mg) 3,5-Me2-4-NO2-pzH were dissolved
in 6 mL CH2Cl2 and stirred for 15 min. To the clear solution equimolar amount of trimethylamine
was added and stirred for 20 min. X-ray quality single crystal were obtained by slow evaporation
of the reaction solution. Using the (NH4)2PdCl4 salt also gave the same compound (82 % yield).
The compound was characterized by SCXRD, 1HNMR and IR. IR(ʋmax, cm-1): 2994 (m, broad),
1544 (m), 1465 (m), 1407 (m), 1351 (s), 1180 (m), 1118 (w), 1024 (w), 995 (w), 835 (m), 765
(w). 1H-NMR (CD3ODCD3, 298K, in ppm, 400MHz): 1.43 (t) (18H, -CH3/Et3NH); 3.40 (q)
(12H, -CH2/ Et3NH); 2.71 (s) (12H, -CH3pz), 2.88 (s) (12H, -CH3pz).
5.3.3.7. Synthesis of (Et3NH)2[Pd3Cl4(-4-NO2-pz)4] [5.7]
0.1 mmol (28.4 mg) (NH4)2PdCl4 and 0.1 mmol (11.3 mg) 4-NO2-pzH were dissolved in 6 mL
MeOH and stirred for 15 min. To the clear solution, an equimolar amount of triethylamine was
added and stirred for 20 min. The reaction solution was allowed for the air concentration. Two
different colored crystals were obtained from the reaction solution and they were manually
separated under the microscope. One with lighter yellow colored crystal was the compound 5.9
and the other with the intense yellow colored crystal turned out to be compound 5.7. (20% yield).
The compound was characterized by SCXRD, IR, 1H-NMR and elemental analysis. Anal. Calcd
for [5.7]: C, 25.88; H, 3.62; N, 17.61. Found: C, 25.66; H, 3.54; N, 17.32. IR(ʋmax, cm-1): 3143
(w), 2983 (w), 2622 (w), 2495 (w), 1531 (m), 1484 (m), 1392 (m), 1351 (s), 1207 (w), 1128 (m),
1058 w), 1031 (w), 970 (w), 823 (s), 781 (m), 744 (s), 669 (w). 1H-NMR (CD3OD, 298K,  in
ppm, 400 MHz): 1.31 (t) (18H, -CH3/ Et3NH); 3.21 (q) (12H, -CH2/ Et3NH); 8.02 (s) (4H, CHpz), 8.26 (s) (4H, -CHpz).
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5.3.3.8. Synthesis of (Et3NH)2[Pd3Cl4(-4-OH-pz)4] [5.8]
0.1 mmol (28.4 mg) (NH4)2PdCl4 and 0.2 mmol (16.8 mg) 4-OH-pzH was dissolved in 5 mL
MeOH and stirred for 10 min. To the clear solution, 0.2 mmol Et3N was added and stirred for 20
minutes. X-ray quality single crystals were obtained by the slow evaporation of the reaction
solution. Yield: undetermined. The compound was characterized by SCXRD.
5.3.3.9. Synthesis of (Et3NH)1.5[Pd3Cl3(μ3-OH0.5)(-4-NO2-pz)3]2 [5.9]
0.1 mmol (28.4 mg) (NH4)2PdCl4 and 0.1 mmol (11.3 mg) 4-NO2-pzH was dissolved in 6 mL
MeOH and stirred for 15 min. To the clear solution, an equimolar amount of triethylamine was
added and stirred for 20 min. The reaction solution was allowed for the air concentration. After 4
days, golden yellow crystals were obtained before the precipitation of Et3NHCl in about 80 %
yield. Instead of (NH4)2PdCl4, PdCl2(CH3CN)2 on the equimolar amount of ligand and base in
CH2Cl2/MeOH also gave the same compound, but due to the solubility issue more precipitate and
less crystal were obtained and yield was about 40%. The compound was characterized by
SCXRD, IR, 1H-NMR and elemental analysis. 1H-NMR (ppm, CD3COCD3): 1.41(27H, t, CH3);
3.41 (18H, q, CH2); 8.18 (12H, s, CHpz). IR (ʋmax cm-1): 3097 (s), 2977 (w), 1500 (s), 1407 (s),
1286 (s), 1170 (m) 1029 (m), 997 (m), 869 (w), 840 (w), 815 (s), 752 (s). Elemental analysis;
found (%) C = 22.89, H = 3.66, N = 16.05; calculated (%) C = 22.55, H = 3.52, N = 15.34.
5.3.2. General procedure for the Sonogashira reactions
To the distilled/degassed MeCN (4 mL) were added 1.00 mmol of aryl iodide, 1.00 mmol of
terminal alkynes, 1.20 mmol of Et3N and 0.009 mmol of catalyst (5.2 or 5.3). The reactions were
stirred at room temperature in open air about 4-6 h. The cprogress of reactions was monitored by
TLC until completion. The products obtained were concentrated in a rotary evaporator and
purified by column chromatography.
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5.3.2.1. Synthesis of diphenylacetylene (1, 1’(1,2-ethynediyl)bis-benzene) (4a)
Purification by column chromatography (100% hexane). 1H-NMR (400 MHz, 298 K,  in ppm,
CDCl3) 7.55-7.53 (4H, m), 7.38-7.33 (6H, m); 13C NMR (400 MHz, 298 K,  in ppm, CDCl3)
131.61, 128.33, 128.24, 123.31, 89.37. Yield: 170 mg (0.97 mmol, 97%).
5.3.2.2. Synthesis of (1-methoxy-4-(2-phenylacetynyl) benzene) (4b, 4e)
Purification by column chromatography (100% hexane). 1H-NMR (400 MHz, 298 K,  in ppm,
CDCl3) 7.53-7.47 (4H, m), 7.34-7.32 (3H, m), 6.89-6.87 (2H, m), 3.83 (3H, s);

13

C NMR

(400MHz, 298K,  in ppm, CDCl3) 159.64, 133.05, 131.45, 128.29, 127.91, 123.63, 115.43,
114.01, 89.37, 88.07, 55.64. Yield (1a): 197 mg (0.95 mmol, 95%), (1d): 190 mg (0.9 mmol, 90
%).
5.3.2.3. Synthesis of (1,3-dimethyl-5-(2-phenylethynylbenzene)) (4c)
Purification by column chromatography (100% hexane). 1H-NMR (400 MHz, 298 K,  in ppm,
CDCl3) 7.52 (2H, m), 7.36-7.34 (3H, m), 7.18 (2H, s), 2.32 (6H, s); 13C-NMR (400 MHz, 298 K,
 in ppm, CDCl3) 137.88, 131.58, 130.19, 129.30, 128.30, 128.07, 123.50, 122.89, 89.73, 88.69,
21.10. Yield: 204 mg (˃99%, ˃0.99 mmol).
5.3.2.4. Synthesis of 1-methyl-4-(2-phenylethynyl)-benzene (4d)
Purification by column chromatography (100% hexane). Yield: 197 mg (97%, 0.97mmol). 1H
NMR (400 MHz, 298 K,  in ppm, CDCl3) 7.53 (2H, m), 7.43 (2H, d), 7.36 – 7.32 (3H, m), 7.16
(2H, d), 2.37 (3H, s).
5.3.2.5. Synthesis of (1, 1’(1,2-ethynediyl)bis(4-methoxybenzene) (4f)
Purification by column chromatography (hexane + ethyl acetate (98:2)). 1H NMR (400 MHz, 298
K,  in ppm, CDCl3) 7.44 (4H, d), 6.88 (4H, d); 13C NMR (400 MHz, 298 K,  in ppm, CDCl3)
159.41, 132.87, 115.76, 113.97, 87.94, 55.18. Yield: 220mg (92%, 0.92 mmol).
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5.3.2.6. Synthesis of 1-methoxy-4-[2-(4methylphenyl)ethynyl]-benzene (4g)
Purification by column chromatography (100% hexane). Yield: 212 mg (95%, 0.95 mmol). 1HNMR (400 MHz, 298 K,  in ppm, CDCl3) 7.46 (2H, d), 7.40 (2H, d), 7.14 (2H, d), 6.87 (2H, d),
3.83 (3H, s), 2.36 (3H, s).
5.3.2.7. Synthesis of 1,3-dimethyl-5-[2-(4-methylphenyl)ethynyl]- Benzene (4h)
Purification by column chromatography (100% hexane). Yield: 210 mg (95%, 0.95mmol). 1HNMR (400 MHz, 298 K,  in ppm, CDCl3) 7.41 (2H, d), 7.16 – 7.14 (4H, m), 6.96 (1H, s), 2.36
(3H, s), 2.31 (6H, s).
5.4. Results and discussions
5.4.1. X-ray data and structure refinement
Block-shaped crystals of the complexes (5.1-5.9) were obtained by recrystallization through slow
evaporation of the reaction solution and/or diffusion of hexanes into their dichloromethane
(CH2Cl2) solutions. Crystal for each complex was selected and mounted on a Bruker D8 Quest
diffractometer equipped with PHOTON 100 detector operating at T = 298 K. Data were collected
with  shutter-less scan technique using graphite monochromated Mo-K radiation (λ = 0.71073
Å). Resolution of  > 25° was achieved in all cases. Cell parameters were retrieved using the
SAINT (Bruker) software and refined using SAINT (Bruker). Data reduction was performed using
the SAINT (Bruker) software, which corrects for Lorentz and polarization effects. Multi-scan
absorption corrections were performed on all data sets using SADABS 2016/2. The structures for
complexes 5.1 and 5.2 were solved by intrinsic phasing using the ShelXT (Sheldrick, 2015)
structure solution program and refined by full-matrix least square procedure on F2 using version
2016/6 of ShelXL. The non-hydrogen atoms were refined anisotropically in all cases. Hydrogen
atom positions were calculated geometrically and refined using the riding model. All calculations
and molecular graphics were performed using either SHELXTL 2014 or Olex2 programs.
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The relatively large thermal ellipsoids (associated with large thermal motion) of certain C atoms
of the counter cations are restrained with Enhanced Rigid Bond Restrain.18 The application of this
restrain enabled to achieve similar displacement parameters (Uij) to emulate rigid body motion.
In few cases, two adjacent atoms were also constrained to have an equivalent atomic
displacement parameter. Certain C-C distances are restrained with DFIX card. The crystal data
and structure refinement parameters for the complexes 5.2 and 5.3 are given in Table 5.1, for
complex 5.9 is given in Table 5.2 and the remaining compounds are listed in Table A5.1 and
Table A5.2. The molecular structure of 5.2 and 5.3 is given in Figure 5.1 and the molecular
structure of 5.9 is given in Figure 5.2. Crystal structures of 5.1, 5.4, and 5.5 are given in Figure
A5.1. Crystal structures of 5.6, 5.7 and 5.8 are given in Figure A5.2.
Table 5.1. Crystal data and structure refinement parameters for the complexes
Formula
Dcalc./ g cm-3
/mm-1
Formula Weight
Color
Shape
T/K
Crystal System
Space Group
a/Å
b/Å
c/Å
/°
/°
/°
V/Å3
Z
Wavelength/Å
Radiation type
min/°
max/°
Measured Refl.
Independent Refl.
Reflections Used
Rint

C18H20Cl4N8O4Pd2 (5.2)
1.699
1.56
783.15
gold
Block
298(2)
Triclinic
P-1
9.7734(5)
11.2516(6)
15.4811(8)
101.824(1)
92.325(1)
11.692(1)
1530.6(1)
2
0.71073
Mo-K
5.60
53.40
26574
6395
5343
0.021
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C30H60Cl8N16O8Pd4 (5.3)
1.794
1.74
1482.14
gold
Block
298(2)
Triclinic
P-1
11.909(1)
12.824(1)
19.497(2)
87.477(2)
80.449(2)
69.196(2)
2744.4(4)
2
0.71073
Mo-K
5.80
53.00
48492
11241
9159
0.036

Table 5.1. Crystal data and structure refinement parameters for the complexes (Continued)
Formula
Parameters
a
GooF
c
wR2
b
R1

a

C18H20Cl4N8O4Pd2 (5.2)
353
1.040
0.109
0.039

C30H60Cl8N16O8Pd4 (5.3)
606
1.030
0.101
0.037

GOF = [[(Fo2-Fc 2)2]/(No-Nv)]1/2 (No = number of observations, Nv = number of variables).
R1 = Fo-Fc/Fo. cwR2 = [((Fo2-Fc2)2/Fo2)]1/

b

Table 5.2. Crystal data and structure refinement parameters for [5.9].
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Crystal size/mm3
Radiation
2 range for data collection/°
Index ranges
Reflections collected
Independent reflections
Data/restraints/parameters
Goodness-of-fit on F2
Final R indexes [I>=2σ (I)]
Final R indexes [all data]
Largest diff. peak/hole / e Å-3

C30H40Cl6N20O14Pd6
1755.92
273.15
Monoclinic
C2/c
26.657(1)
17.0681(8)
15.9050(7)
90
117.100(1)
90
6442.0(5)
4
1.810
1.952
3400.0
0.146 × 0.067 × 0.027
MoKα (λ = 0.71073)
5.574 to 54.98
-33 ≤ h ≤ 33, -21 ≤ k ≤ 21, -20 ≤ l ≤ 20
68251
6763 [Rint = 0.0481, Rsigma = 0.0524]
6763/0/350
1.055
R1 = 0.0584, wR2 = 0.1502
R1 = 0.1001, wR2 = 0.1699
1.81/-0.98
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Figure 5.1. Molecular structure of 5.2 (left) and 5.3 (right). Color code: C, black; N, blue; Cl,
green; O, red; Pd, cyan; H-atoms are omitted for clarity.

Figure 5.2. The molecular structure of 5.9 (single trimeric unit, left) and (whole hexamer, right).
Color code: C, black; H, white; N, blue; Cl, green; O, red; Pd, cyan;H-atoms, except H-bonding,
are omitted for clarity.
5.4.2. NMR analysis
The 1H-NMR spectra of the compounds are unexceptional. For all the compounds, acetone-d6 was
used as a NMR solvent. 5.9 has three Et3N counter ions, consistent with the H-bonded dimer-oftrimer formulation. Although two doublets were expected for compound 5.2, it has three doublets
in the aromatic regions. This might be because the compound exists in two different isomeric
forms (C2 and Cs) in the solution. Attempts to crystallize both isomers failed and, in all cases,
only the Cs isomer was obtained. 1H-NMR data are of the compounds are given in the
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experimental section. NMR spectra of 5.2 and 5.9 are given in Figures 5.3 and 5.4. NMR spectra
of other compounds are given in appendices, Figures A5.3 – A5.6.

Figure 5.3. 1H-NMR of 5.2 (in acetone)

Figure 5.4. 1H-NMR of 5.9 (in acetone)
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5.4.3. Catalytic study
The reaction conditions, such as the most commonly used solvents and bases, were optimized for
one reaction and applied for the rest of the reactions. The palladium precursors PdCl2 and
PdCl2(CH3CN)2 were also used as a catalyst but resulted in yield significantly lower than 5.2 or
5.3. Presence or absence of CuI was also studied for the reaction and concluded that CuI is the
main culprit for homocoupling reactions. Optimization conditions are listed in Table 5.3. Low
catalytic loading (0.9 mol%) was sufficient to proceed with the reaction to completion. Turnover
number (TON) of the catalysts are at least 103 to 108. The chemical nature of alkyl/aryl halide
(R-X) is crucial for the Sonogashira catalysis. Although electron withdrawing groups reduce the
electron density of C-X bond, weakening the bond and making reaction easier,14 no significant
effect was observed in our study; this might be because for all the cases the yield is very high (92
– 99 %). However, for the same product 4b (4e), use of 4-methoxyiodobenzene and 4iodobenzene gave 95% and 92% yields, respectively, consistent with the C-I weakening effect of
methoxy substituent and accelerating the reaction. Catalyst 5.3 was found to be slightly superior
to 5.2 (Table 5.3), because the methyl substituents in 5.3, make the catalyst bulkier, favoring
oxidative addition and reductive elimination steps.10 All other reactions were carried out by using
catalyst 5.3. For all reactions the isolated yield achieved was 92% or higher. The reactions are
listed in Table 5.4.
5.4.4. Terminal –Cl substitution of 5.9 by –CN
Compound 5.9 is a hexanuclear compound (dimer of trimer) containing six terminal chloride (Cl)
atoms. Addition of equimolar AgCN on the MeCN solution of 5.9 tarnishes the original yellow
color of the solution with the formation of a white precipitate. Further addition of AgCN results
more white ppt and color further tarnishes. However, six equivalent or more AgCN is required to
completely remove the yellow color. The color change is the preliminary confirmation of the –Cl
substitution by –CN. The original color of the [5.9] and after complete addition of AgCN is
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shown in Figure 5.5. This was further confirmed by FT-IR. After complete addition of AgCN, an
additional –CN peak in 2136 cm-1 appears along with all the other peaks that are very slightly
shifted (Figure 5.6). The –CN peaks of AgCN appears in 2162 cm-1. The comparison of IR of 5.9
and after substitution is shown in Figure 5.6.
Table 5.3. Optimization of Reaction Conditionsa
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Table 5.4. Sonogashira coupling reactions carried out for this work

Figure 5.5. [5.9] before adding AgCN (left) and after adding AgCN (right)
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Figure 5.6. IR comparison of 5.9 and after –Cl substitution by –CN.
5.5. Conclusions
In summary, nine new palladium pyrazolyl complexes (5.1-5.9) were synthesized ranging from
mononuclear to hexanuclear ones. Three of them are water soluble and they are potential
candidates for green catalysis applications These compounds are characterized by SCXRD, 1H
NMR, FT-IR, and elemental analyses. Compound 5.2 exist in isomeric forms in the solution, as
determined by 1H NMR. The hexanuclear compound 5.9 (dimer-of-trimer) has an unprecedented
motif, which prompted us to further explore its chemistry. Terminal –Cl atoms were replaced by
–CN. The color change was the preliminary indication of the reaction and which was further
confirmed by FT-IR. Two dimers, 5.2 and 5.3, were used as catalysts to synthesize the
Sonogashira products 4a and 5.3, the latter having a slightly higher yield. Compound 5.3 was
slightly superior to 5.2, which might be caused by the steric effect of –CH3 groups in the 3- and
5-position of the pyrazole. All other reactions were catalyzed by 5.3. These types of pyrazolyl
dimer complexes have not been ported previously, at least for the cross-coupling reactions. The
catalysis reactions were carried out in an open air atmosphere, without Cu(I), relatively short
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reaction times and mild conditions. This might open up a new horizons for a catalytic system for
the cross-coupling reactions to overcome limitations of the existing catalytic system.
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CHAPTER 6

6.1. Overall conclusions
In summary, the dissertation work contains six chapters including the general introduction and the
general conclusions in chapters 1 and 6 respectively. The first project (second chapter) contains
the synthesis and characterization the water-soluble, biocompatible silver pyrazolates complexes
for bio-medicinal applications and one of the water-soluble compounds proved to be highly
effective compared to AgNO3 for inhibiting/killing the gram negative bacteria. The ligands and
co-ligands chosen for this project are biocompatible. To the best of our knowledge, it is the first
report of an antibacterial/medicinal application using silver pyrazolates. Although several silver
pyrazolate complexes are found in the literature with the study of their chemical and physical
properties, no medicinal applications have been reported previously. We also proved that watersoluble silver pyrazolates are better over water-insoluble ones with regard to their antibacterial
properties. The need for the slow delivery of Ag+ ions to the target has been accomplished.
Exploiting the versatility of pyrazolyl ligands, we explored their applications in luminescent
sensors. In this work (third chapter) we designed tripodal pyrazolyl ligands and probed their
nitroaromatic sensing behaviors. To our best knowledge, we used the new tripodal pyrazolyl
ligands for the first time for the application with fascinating results. Although relatively newer,
the cutting edge research area of sensing using AIEE property was well introduced. The selective
sensing of picric acid over other nitroaromatics has been experimentally demonstrated.
The literature for the mercury pyrazolate lacks examples for the higher coordination number
modes. According to the Cambridge structural database (CSD), mercury pyrazolates with only
coordination numbers 2, 3 and 4 are reported. Also, most of the pyrazolates isolated were
polymers, which limits their solubility and prevents the growth of single crystals; Most of the
structures had been elucidated by powder diffraction technique. All the hitherto reported work
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involves mercury pyrazolates of only four pyrazoles: Hpz, dmpzH, dPhpzH, and diisopropylpzH.
Also, no literature was found reporting pyrazole-based ligands for selective extraction purposes.
We have synthesized a variety of mercury pyrazolates with a great range of nuclearity, solubility,
and coordination number. Some of the polymers we synthesized are highly soluble in organic
media. We have synthesized a C-mercuriated complex. Only one C-mercuriated Hg-pyrazolate
exists in the literature. We have synthesized an Hg-pyrazolate with a tripodal ligand. No literature
was found reporting a pyrazolyl mercury complex with a tripodal pyrazole. The tripodal ligand
was used to extract mercury and found promising. We have tuned the solvents and stoichiometry
for the same reactants and synthesized various compounds. All five ligands employed are
structurally highly different from one another. We have synthesized the mercury pyrazolates
having all the geometry reported previously as well as a new octahedral geometry for the mercury
pyrazolates. The work has been reported in chapter four. The literature reported deals with the
synthesis and characterization of mercury pyrazolates aiming to explore the chemistry. Our
primary objective is to design the ligands which are good to extract mercury from the mixture of
lanthanides and actinides in an aqueous alkaline solution. Added toxicological effect to the
worker in Savannah River nuclear waste site prompted us to design the project. Preliminary result
for the extraction study is successful and the ligands we design are stable in acidic to alkaline
conditions. Some of the work on liquid-liquid extraction of mercury have been reported already.
They have found that lipophilicity is an important parameter for the extraction to the organic
phase. Although much work has been reported for the extraction of mercury, most of them are
limited to extraction in acidic media and use of sulfur donor extractants. No pyrazolate ligands for
the extraction of mercury have been reported yet.
Nine new palladium pyrazolyl complexes with a broad range of solubility have been synthesized
and characterized with SCXRD, standard spectroscopic techniques, and elemental analyses. Two
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of them were used as a catalyst for Sonogashira coupling reactions and found promising. The
catalytic products were characterized by NMR.

6.2. Future work
In the future, we will be pursing antimicrobial activity of water-soluble silver pyrazolate
complexes in wider scope. Optimization of synthetic routes of water-soluble palladium
pyrazolates and use them as a catalyst for green catalysis will be our another project in future.
Moreover, further investigation of mercury pyrazolate chemistry will also be pursued.

APPENDICES
Figures

Figure A2.1. Perspective view of the molecular structure of complexes 2.3 (left) and 2.4 (right).
The thermal ellipsoids are shown at 35% probability level (H atoms are omitted, and the labeling
scheme are shown only for the hetero atom for the sake of clarity). Color code: C, black; N, blue;
O, red; P, pink and Ag, yellow.
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Figure A2.2. Perspective view of the molecular structure of complexes 2.7 (left) and 2.8 (right).
The thermal ellipsoids are shown at 35% probability level (H atoms are omitted and the labeling
scheme are shown only for the hetero atom for the sake of clarity). Color code: C, black; N, blue;
P, pink and Ag, yellow.

Figure A3.1. 1H NMR spectrum of compound 3.1, DMSO-d6. (Top: Expanded aromatic region)
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Figure A3.2. 1H-NMR spectrum of compound 3.3, CDCl3. (Top: Expanded aromatic region)

Figure A3.3. 1H-NMR spectrum of compound 3.4, CDCl3. (Top: Expanded aromatic region)
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Figure A3.4. 1H-NMR spectrum of compound 3.5, CDCl3.

Figure A3.5. IR spectrum of compound 3.1.
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Figure A3.6. IR spectrum of compound 3.3.
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Figure A3.7. IR spectrum of compound 3.4.

Figure A3.8. IR spectrum of compound 3.5.

Figure A3.9. (a) UV – visible spectra of 3.2 in THF with the addition of water (0 to 90%). (b)
Photographs of 3.3 before (a) and after (b) in THF and THF/H2O (20:80) mixture.
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Figure A3.10. UV – visible spectra for 3.1 in THF with the gradual addition of water from 0 to
90%.

Figure A3.11. DLS data for the aggregates of 3.1 (15 µM) in THF/H2O (20:80) mixture.
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Figure A3.12. DLS data for the aggregates of 3.2 (15 µM) in THF/H2O (20:80) mixture.

Figure A3.13. DLS data for the aggregates of 3.3 (15 µM) in THF/H2O (20:80) mixture.

Figure A3.14. Fluorescence spectra of 3.2 (15 µM) with the addition of water from 0 to 90% into
THF.
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Figure A3.15. Fluorescence spectra of 3.2 (15 µM) in a THF/H2O mixture (10:90 v/v) at
different aging times. (Δt = 5 mins)

Figure A3.16. Frequency modulation data for 3.2 in THF. (τ = 1.2 ns)

120

Figure A3.17. Frequency modulation data for 3.2 in THF/H2O (10:90) mixture. (τ = 1.8 ns)

Figure A3.18. Variation of fluorescence intensity of compound 3.1 & 3.2 (15 µM) in
THF/ethylene glycol (EG) mixture. (0, 20, 40, 60, 80 & 90 volume fraction of EG in THF)
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Figure A3.19. Variation of fluorescence intensity of compound 3.3 (15 µM) in THF/ethylene
glycol (EG) mixture. (0, 20, 40, 60, 80 & 90 volume fraction of EG in THF)

.
Figure A3.20. Absorption spectral changes of 3.1 & 3.2 (15 µM) in THF/H2O (20:80) with the
addition of PA (0 to 20µM)
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Figure A3.21. Absorption spectral changes of 3.3 (15 µM) in THF/H2O (20:80) with the addition
of PA (0 to 20µM)

Figure A3.22. Emission spectra of 3.3 (15µM) in THF/H2O (20:80) upon addition of PA from 0
to 30µM.
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Figure A3.23. (a) Stern-Volmer plot for the complex 3.1 with PA (b) SV plot obtain at lower
concentration of PA.

Figure A3.24. (a) Stern-Volmer plot for the complex 3.3 with PA (b) SV plot obtain at lower
concentration of PA.
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Figure A3.25. Photographs taken before (A) Complex 3.2 and 3.2+PA after (B) Compound 3.2
and 3.2+ PA.

Figure A3.26. Partial 1H-NMR spectra of 3.2 and 3.2-PA.
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Figure A3.27. Photographs of compound 3.2 impregnated test paper strips upon exposure to the
vapors of PA. (0 min, 5 min, 10 min and 20 min from left to right respectively.

Figure A4.1. 1H-NMR of 4.1., CD3COCD3
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Figure A4.2. 1H-NMR of 4.2., CDCl3

Figure A4.3. 1H-NMR of 4.5., CDCl3
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Figure A4.4. 1H-NMR of 4.6., CDCl3

Figure A4.5. 1H-NMR of 4.7., CDCl3
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Figure A5.1. Molecular structures of 5.1 (bottom), 5.4 (top right) and 5.5 (top left). Color code:
C, black; H, white; N, blue; Cl, green; O, red; Pd, cyan. (H-atoms are omitted for clarity, except
for N-H in 5.1)

Figure A5.2. Molecular structures of 5.6 (top right), 5.7 (top left) and 5.8 (bottom). Color code:
C, black; H, white; N, blue; Cl, green; O, red; Pd, cyan. (H-atoms are omitted for clarity)
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Figure A5.3. 1H-NMR of 5.3., CD3COCD3

Figure A5.4. 1H-NMR of 5.4., CD3COCD3
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Figure A5.5. 1H-NMR of 5.6., CD3COCD3

Figure A5.6. 1H-NMR of 5.6., CD3OD
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Tables
Table A2.1. Crystal data and structure refinement parameters for complexes 2.6-2.8

-3

Dcalc./ g cm
/mm-1
Formula Weight
Color
Shape
T/K
Crystal System
Space Group
a/Å
b/Å
c/Å
/°
/°
/°
V/Å3
Z
Wavelength/Å
Radiation type
min/°
2max/°
Measured Refl.
Independent Refl.
Reflections Used
Rint
Parameters
a
GooF
c
wR2
b
R1

C18H28Ag2Cl2N10P2
1.610
1.602
733.08
Colorless
Block
298(2)
Monoclinic
C2/c
24.956(7)
6.1178(17)
19.893(6)
90
95.248(7)
90
3024.6(15)
4
0.71073
Mo-Kα
5.49
53
21517
3127
2442
0.069
154
1.087
0.0944
0.0453

C60H49Ag2N4Cl2P3
1.722
1.627
862.10
Colorless
Block
298(2)
Monoclinic
P21/n
6.1657(7)
21.732(2)
12.4739(13)
90
95.841(3)
90
1662.8(3)
2
0.71073
Mo-Kα
6.51
52.86
28168
3412
1868
0.15
182
1.070
0.11
0.074

a

C22H38Ag2Cl4N10P2
1.747
1.605
862.10
Colorless
Block
298(2)
Monoclinic
P21/n
6.571(3)
19.140(9)
13.116(6)
90
96.390(9)
90
1639.3(13)
2
0.71073
Mo-Kα
6.25
53.80
27783
3523
2560
0.069
182
1.116
0.0843
0.0461

GOF = [[(Fo2-Fc 2)2]/(No-Nv)]1/2 (No = number of observations, Nv = number of variables).
b
R1 = Fo-Fc/Fo. cwR2 = [((Fo2-Fc2)2/Fo2)]1/2
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Table A2.2. Selected bond distances (Å) and angles (°) for 2.3
Complex 2.3
Ag1−P1
2.5017(12)
Ag1−P2
2.4868(12)
Ag1−N1
2.307(4)
Ag1−N2a
2.378(4)
P2−Ag1−P1
120.75(4)
N1−Ag1−P2
110.74(11)
N1−Ag1−P1
114.88(11)
N1−Ag1−N2a
96.10(14)
N2a−Ag1−P2
105.86(11)
N2−Ag1−P1
104.75(10)
The a-labeled atoms are generated by the −x+1, −y+2, −z+1 symmetry operation
Table A2.3. Selected bond distances (Å) and angles (°) for 2.4
Complex 2.4
Ag1−P1
Ag1−P2
Ag1−N1
Ag1−N4
P1−Ag1−P2
N4−Ag1−P2
N4−Ag1−P1
N4−Ag1−N1
N1−Ag1−P2
N1−Ag1−P1

2.4694(8)
2.4948(8)
2.373(3)
2.355(3)
124.62(3)
105.26(8)
115.20(7)
97.24(11)
108.56(8)
102.28(8)

Ag2−P3
Ag2−N5
Ag2−N2

2.3789(8)
2.187(3)
2.278(3)

N5−Ag2−P3
N5−Ag2−N2
N2−Ag2−P3

144.74(8)
105.06(11)
109.14(8)
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Table A2.4. Selected bond distances (Å) and angles (°) for 2.6-2.8

Ag1-P1
Ag1-N1
Ag1-N2
N1-Ag1-P1
N1-Ag1-N21
N21-Ag1-P1

2.6
2.3630(12)
2.224(4)
2.238(4)
126.73(10)
107.47(13)
125.67(10)

2.7
2.3618(19)
2.169(6)
2.263(6)
132.66(17)
108.3(2)
116.53(17)

2.8
2.3654(13)
2.186(3)
2.251(4)
133.31(10)
108.48(12)
117.72(10)

Table A3.1. 1H NMR shifts (ppm) 3.1, 3.3-3.5
Compound

A (9H,t)

B (6H, q)

C (6H, s)

Phenyl protons

Pyrazolyl
Protons

[3.1] (ppm,
(CD3)2SO)

0.88

2.87

5.44

7.89 (3H, s)
7.96 (3H, s)

[3.3] (ppm, CDCl3)

1.02

2.82

5.50

[3.4] (ppm, CDCl3)

1.05

2.84

5.53

7.16 (3H, t)
7.29 (6H, t)
7.51 (6H, d)
7.16-7.24 (9H)
7.37 (3H,S)
7.51 (6H, d)
8.12 (6H, d)

[3.5] (ppm, CDCl3)

0.93

2.71

5.43

A: -CH3 (ethyl)

B: -CH2 (ethyl)

C: -CH2 (-CH2-pz*)
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7.33 (3H, s)
7.81(3H, s)
7.53 (3H, s)
7.89 (3H, s)
7.07 (3H, s)
7.55 (3H, s)

Table A3.2. 1H NMR spectra of ligands (3.1-3.3) and ligands + picric acid in CDCl3.

B
C
D
Compounds A
(9H,t) (6H,q) (6H,s) [3H,s,PzC(3)]
PA
[3.1]

1.05

2.82

5.50

7.82

[3.1-PA]
(1:1)
[3.1-PA]
(1:2)
[3.1-PA]
(1:3)
Compounds

1.06

2.81

5.53

7.85

1.06

2.81

5.54

7.86

1.07

2.81

5.57

7.89

[3.2]

0.65

2.56

5.25

6.56

[3.2-PA]
(1:1)

0.73

2.59

5.29

6.57

7.25 (9H), 7.34 + 7.36
(9H)
7.24 (9H), 7.30 (3H),
7.34 + 7.36 (6H)
7.24 (9H), 7.34 (9H)

A
B
C
D
(9H,t) (6H,q) (6H,s) [3H,s,PzC(4)]

Compounds A
B
C
D
(9H,t) (6H,q) (6H,s) [3H,s,PzC(3)]
[3.3]
1.02
2.82
5.50
7.81

[3.3-PA]
(1:1)

1.04

2.82

5.52

[18H, benzene ring + PA (s, PA(s,Pz-C(5)]
-CH)
OH)

7.84
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7.23 (6H), 7.27 (3H),
7.36 (9H)
Benzene ring (30H)

7.18 - 7.24 (6H), 7.36
(15H), 7.43 - 7.47
(3H), 7.73(6H)
7.11 - 7.17 (9H), 7.43
(12H), 7.59(6H), 7.77
(3H)
[15H, benzene ring +
Pz-C(5)]
7.16 - 7.24 (9H), 7.37
(3H),
7.33 (3H)
7.15-7.23 (9H), 7.36 7.38 (6H)

9.20

11.97

9.13

7.30

9.15

7.32

9.14

7.38

PA (s, PA(s,-CH)
OH)

9.05

8.01

PA (s,
-CH)

PA(s,OH)

9.16

7.36

Table A4.1. Crystallographic table of Hg complexes [4.1-4.3]
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Radiation
2Θ range for data collection/°
Index ranges
Reflections collected
Independent reflections
Data/restraints/parameters
Goodness-of-fit on F2
Final R indexes [I>=2σ (I)]
Final R indexes [all data]
Largest diff. peak/hole / e Å-3

C6H4Cl4Hg2I2N4 [4.1]
928.91
298 (2)
Triclinic
P-1
8.379(6)
9.977(6)
10.808(6)
75.757(15)
80.29(2)
74.81(2)
839.9(9)
2
3.673
22.556
804.0
MoKα (λ = 0.71073)
5.858 to 52.86
-10 ≤ h ≤ 10, -12 ≤ k ≤ 12, 13 ≤ l ≤ 13
8083
3337 [Rint = 0.0441, Rsigma =
0.0549]
3337/0/163
1.144
R1 = 0.0558, wR2 = 0.1578
R1 = 0.0930, wR2 = 0.1721
2.70/-3.73

C42H58Cl4Hg4N20O12 [4.2]
1979.24
298 (2)
orthorhombic
P212121
15.6614(16)
19.778(2)
21.694(2)
90
90
90
6719.6(12)
4
1.956
9.335
3736.0
MoKα (λ = 0.71076)
5.902 to 48.36
-17 ≤ h ≤ 18, -22 ≤ k ≤ 22, 24 ≤ l ≤ 24
113981
10707 [Rint = 0.0548, Rsigma =
0.0398]
10707/961/747
1.005
R1 = 0.0537, wR2 = 0.0981
R1 = 0.1186, wR2 = 0.1232
0.99/-1.09
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C5H3Cl2Hg2.5N3O4 [4.3]
741.48
298 (2)
Monoclinic
P21/c
8.6198(7)
18.7637(15)
8.1631(7)
90
115.656(2)
90
1190.13(17)
4
4.138
32.637
1280.0
MoKα (λ = 0.71076)
5.948 to 52.916
-10 ≤ h ≤ 10, -23 ≤ k ≤ 23, 10 ≤ l ≤ 10
21737
2451 [Rint = 0.0334, Rsigma =
0.0188]
2451/0/152
1.115
R1 = 0.0311, wR2 = 0.0815
R1 = 0.0373, wR2 = 0.0842
2.50/-2.11

Table A4.2. Crystallographic table of Hg complexes [4.4-4.6]
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Crystal size/mm3
Radiation
2Θ range for data
collection/°
Index ranges

Reflections collected
Independent reflections

Data/restraints/parameters
Goodness-of-fit on F2
Final R indexes [I>=2σ (I)]
Final R indexes [all data]
Largest diff. peak/hole / e
Å-3

C5H6ClHgN3O2
[4.4]
376.17
298 (2)
orthorhombic
Cmce
23.8871(10)
6.5063(3)
10.8561(4)
90
90
90
1687.22(12)
8
2.962
18.522
1360.0
0.055 × 0.048 ×
0.045
MoKα (λ =
0.71076)
6.824 to 52.752

C6H6Cl4Hg2I2N4
[4.5]
930.93
298 (2)
Triclinic
P-1
8.379(6)
9.977(6)
10.808(6)
75.757(15)
80.29(2)
74.81(2)
839.9(9)
2
3.681
22.555
808.0
0.273 × 0.19 ×
0.075
MoKα (λ =
0.71073)
6.424 to 52.86

C6H6Cl2HgI2N4
[4.6]
659.44
298 (2)
monoclinic
P21/c
4.1895(7)
15.189(2)
10.1794(14)
90
94.619(4)
90
645.66(16)
2
3.392
17.089
580.0
0.13 × 0.12 ×
0.075
MoKα (λ =
0.71076)
6.702 to 52.66

-29 ≤ h ≤ 29, -8
≤ k ≤ 8, -13 ≤ l ≤
13
10810
887 [Rint =
0.0313, Rsigma =
0.0160]
887/0/60
1.068
R1 = 0.0238,
wR2 = 0.0559
R1 = 0.0303,
wR2 = 0.0582
2.50/-1.28

-10 ≤ h ≤ 10, -12
≤ k ≤ 12, -13 ≤ l
≤ 13
8018
3314 [Rint =
0.0441, Rsigma =
0.0549]
3314/0/157
1.144
R1 = 0.0551,
wR2 = 0.1530
R1 = 0.0916,
wR2 = 0.1688
2.67/-3.86

-5 ≤ h ≤ 5, -18 ≤
k ≤ 18, -12 ≤ l ≤
12
8603
1314 [Rint =
0.0231, Rsigma =
0.0155]
1314/0/70
1.216
R1 = 0.0189,
wR2 = 0.0420
R1 = 0.0216,
wR2 = 0.0427
0.45/-1.22
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Table A5.1. Crystallographic table of 5.1, 5.4, 5.5.
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Crystal size/mm3
Radiation
2Θ range for data collection/°
Index ranges
Reflections collected
Independent reflections
Data/restraints/parameters
Goodness-of-fit on F2
Final R indexes [I>=2σ (I)]
Final R indexes [all data]
Largest diff. peak/hole / e Å-3

C12H20Cl2N4O2Pd [5.1]
429.62
298(2)
Triclinic
P-1
7.2002(9)
8.0525(10)
8.2801(11)
112.642(3)
111.018(3)
92.970(3)
403.43(9)
1
1.768
1.490
216.0
0.224 × 0.104 × 0.084
MoKα (λ = 0.71073)
5.848 to 52.896
-9 ≤ h ≤ 9, -10 ≤ k ≤ 10, -10
≤ l ≤ 10
4807
1654 [Rint = 0.0249, Rsigma =
0.0285]
1654/0/98
1.147
R1 = 0.0335, wR2 = 0.0845
R1 = 0.0361, wR2 = 0.0861
1.37/-0.56

C30H53Cl8N16O8Pd4 [5.4]
1475.08
298 (2)
Triclinic
P-1
11.9582(9)
12.7550(10)
19.2701(15)
86.753(2)
79.580(2)
69.696(2)
2711.1(4)
2
1.807
1.757
1458.0
0.169 × 0.102 × 0.098
MoKα (λ = 0.71073)
5.968 to 56.696
-15 ≤ h ≤ 15, -17 ≤ k ≤ 17, -25
≤ l ≤ 25
66397
13191 [Rint = 0.0500, Rsigma =
0.0564]
13191/0/604
1.351
R1 = 0.0960, wR2 = 0.1376
R1 = 0.1233, wR2 = 0.1462
1.63/-1.19
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C11H22.5Cl2N3OPd [5.5]
390.12
298 (2)
Triclinic
P-1
9.3256(6)
12.4381(8)
14.5995(10)
87.859(2)
71.663(2)
85.740(2)
1602.83(18)
4
1.617
1.484
790.0
0.300 × 0.200 × 0.100
MoKα (λ = 0.71073)
5.836 to 53.782
-11 ≤ h ≤ 11, -15 ≤ k ≤ 15, 18 ≤ l ≤ 18
20929
6734 [Rint = 0.0220, Rsigma =
0.0270]
6734/0/342
0.999
R1 = 0.0315, wR2 = 0.0804
R1 = 0.0400, wR2 = 0.0863
1.32/-0.55

Table A5.2. Crystallographic table of 5.6-5.8
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Crystal size/mm3
Radiation
2Θ range for data collection/°
Index ranges
Reflections collected
Independent reflections
Data/restraints/parameters
Goodness-of-fit on F2
Final R indexes [I>=2σ (I)]
Final R indexes [all data]
Largest diff. peak/hole / e Å-3

C32H54Cl4N14O8Pd3 [5.6]
1223.89
298 (2)
Triclinic
P-1
10.0414(8)
11.0767(9)
11.3946(9)
84.703(2)
89.201(2)
73.399(2)
1209.25(17)
1
1.681
1.383
614.0
0.224 × 0.104 × 0.084
MoKα (λ = 0.71073)
5.848 to 52.944
-12 ≤ h ≤ 12, -13 ≤ k ≤ 13, 14 ≤ l ≤ 14
15602
4731 [Rint = 0.0413, Rsigma =
0.0532]
4731/0/283
1.267
R1 = 0.1036, wR2 = 0.1869
R1 = 0.1344, wR2 = 0.2064
2.53/-1.46

C24H40Cl4N14O8Pd3 [5.7]
1113.70
298 (2)
Triclinic
P-1
9.3076(15)
9.5228(15)
12.1185(19)
84.440(5)
76.779(5)
74.232(5)
1005.6(3)
1
1.839
1.653
552.0
0.092 × 0.067 × 0.054
MoKα (λ = 0.71073)
5.53 to 53.49
-11 ≤ h ≤ 11, -12 ≤ k ≤ 12, 15 ≤ l ≤ 15
11672
4203 [Rint = 0.0668, Rsigma =
0.0944]
4203/0/248
1.037
R1 = 0.0501, wR2 = 0.0883
R1 = 0.0994, wR2 = 0.1013
0.72/-0.64
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C24H44Cl4N10O4Pd3 [5.8]
997.69
298 (2)
Monoclinic
P21/n
10.2480(5)
16.2671(7)
10.4861(5)
90
93.432(2)
90
1744.95(14)
2
1.899
1.882
992.0
0.123 ×0.089 × 0.084
MoKα (λ = 0.71073)
5.732 to 52.836
-11 ≤ h ≤ 11, -12 ≤ k ≤ 12, 14≤ l ≤ 14
3569
3569 [Rint = 0.0668, Rsigma =
0.1002]
3569/0/210
1.172
R1 = 0.1064, wR2 = 0.1857
R1 = 0.1644, wR2 = 0.2050
1.32/-1.37
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